| 1 | Rasopathy | Enrichment | BRAF, HRAS, KRAS, MAP2K1, MAP2K2, MRAS, NRAS, RAF1, RRAS2, SOS1, SOS2 | 16.00 |
| 2 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | COL1A1, COL3A1, COL5A1, COL5A2, EFEMP2, ELN, FBN1, FBN2, TGFB2, TGFB3, TGFBR1, TGFBR2 | 16.00 |
| 3 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, FBN2, TGFB2, TGFBR2 | 10.93 |
| 4 | Noonan syndrome 1 | Enrichment | BRAF, HRAS, KRAS, MAP2K1, MAP2K2, MRAS, NRAS, RAF1, RRAS, RRAS2, SOS1, SOS2 | 10.75 |
| 5 | Connective tissue disease | Enrichment | COL11A1, COL12A1, COL2A1, COL5A1, COL9A1, COL9A3, EFEMP1, FBN1, TGFBR2 | 10.50 |
| 6 | Noonan syndrome and noonan-related syndrome | Enrichment | BRAF, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1, SOS1 | 10.45 |
| 7 | Marfan syndrome | Enrichment | COL2A1, FBN1, FBN2, TGFB2, TGFBR1, TGFBR2 | 10.20 |
| 8 | Stickler syndrome | Enrichment | COL11A1, COL2A1, COL9A1, COL9A2, COL9A3, VCAN | 10.20 |
| 9 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2, TGFBR1 | 9.69 |
| 10 | Junctional epidermolysis bullosa | Enrichment | COL17A1, ITGA6, ITGB4, LAMA3, LAMB3, LAMC2 | 9.44 |
| 11 | Human immunodeficiency virus type 1 | Enrichment | CCL11, CCL2, CCL3, CCL3L1, CCL5, CCR2, CCR5, CXCL12, CXCR1 | 9.09 |
| 12 | Epidermolysis bullosa, junctional 1a, intermediate | Enrichment | COL17A1, ITGB4, LAMA3, LAMB3, LAMC2 | 8.70 |
| 13 | Junctional epidermolysis bullosa non-herlitz type | Enrichment | COL17A1, ITGB4, LAMA3, LAMB3, LAMC2 | 8.70 |
| 14 | Lung non-small cell carcinoma | Enrichment | BRAF, EGFR, HRAS, KRAS, MAP2K1, NRAS | 8.54 |
| 15 | Loeys-dietz syndrome | Enrichment | FBN1, TGFB2, TGFB3, TGFBR1, TGFBR2 | 8.42 |
| 16 | Bethlem muscular dystrophy | Enrichment | COL12A1, COL6A1, COL6A2, COL6A3 | 8.40 |
| 17 | Ullrich congenital muscular dystrophy 1a | Enrichment | COL12A1, COL6A1, COL6A2, COL6A3 | 7.71 |
| 18 | Cardiofaciocutaneous syndrome 1 | Enrichment | BRAF, KRAS, MAP2K1, MAP2K2 | 7.45 |
| 19 | Cardiofaciocutaneous syndrome | Enrichment | BRAF, KRAS, MAP2K1, MAP2K2 | 7.45 |
| 20 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 7.23 |
| 21 | Multiple epiphyseal dysplasia due to collagen 9 anomaly | Enrichment | COL9A1, COL9A2, COL9A3 | 6.30 |
| 22 | Collagen vi-related dystrophies | Enrichment | COL6A1, COL6A2, COL6A3 | 6.30 |
| 23 | Intermediate collagen vi-related muscular dystrophy | Enrichment | COL6A1, COL6A2, COL6A3 | 6.30 |
| 24 | Digenic alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 6.30 |
| 25 | Nevus, epidermal | Enrichment | COL7A1, HRAS, KRAS, NRAS | 6.04 |
| 26 | Nephrotic syndrome | Enrichment | COL4A3, COL4A4, COL4A5, FN1, LAMA5, LAMB2 | 5.95 |
| 27 | Thyroid cancer, nonmedullary, 2 | Enrichment | BRAF, HRAS, NRAS, PTEN | 5.92 |
| 28 | Noonan syndrome 3 | Enrichment | HRAS, KRAS, RAF1, SOS1 | 5.92 |
| 29 | Follicular thyroid carcinoma | Enrichment | BRAF, HRAS, NRAS, PTEN | 5.92 |
| 30 | Autosomal recessive stickler syndrome | Enrichment | COL9A1, COL9A2, COL9A3 | 5.70 |
| 31 | Breast implant-associated anaplastic large cell lymphoma | Enrichment | JAK1, JAK2, STAT3 | 5.68 |
| 32 | Melanocytic nevus syndrome, congenital | Enrichment | BRAF, HRAS, NRAS, RAF1 | 5.62 |
| 33 | Langerhans cell histiocytosis | Enrichment | BRAF, MAP2K1, NRAS | 5.58 |
| 34 | Chronic granulomatous disease | Enrichment | CYBA, CYBB, NCF1, NCF2, NCF4 | 5.53 |
| 35 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ACTG1, COL11A1, COL11A2, MYH14, MYH9, MYO1A, MYO1C, MYO6, MYO7A, TNC | 5.49 |
| 36 | Mccune-albright syndrome | Enrichment | COL2A1, FBN1, GNAS | 5.34 |
| 37 | Alport syndrome 3a, autosomal dominant | Enrichment | COL4A3, COL4A4, COL4A5 | 5.30 |
| 38 | Autosomal dominant alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 5.30 |
| 39 | Alport syndrome | Enrichment | COL4A3, COL4A4, COL4A5 | 5.30 |
| 40 | Myopia | Enrichment | COL11A1, COL2A1, COL4A4, FBN1 | 5.30 |
| 41 | Kidney disease | Enrichment | COL4A3, COL4A4, COL4A5, LAMB2 | 5.30 |
| 42 | Skin disease | Enrichment | COL17A1, COL7A1, ITGB4, LAMB3, LAMC2 | 5.13 |
| 43 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS, KRAS, NRAS | 5.08 |
| 44 | Epidermolysis bullosa, junctional 1b, severe | Enrichment | LAMA3, LAMB3, LAMC2 | 5.00 |
| 45 | Inguinal hernia | Enrichment | COL5A1, EFEMP1, FBN1 | 5.00 |
| 46 | Keratoconus | Enrichment | COL1A1, COL4A1, COL5A2 | 5.00 |
| 47 | Juvenile myelomonocytic leukemia | Enrichment | ARHGAP26, KRAS, NRAS, RRAS | 4.79 |
| 48 | Myopathy | Enrichment | ACTA1, CAPN3, COL6A1, COL6A2, COL6A3, FBN1 | 4.77 |
| 49 | Bethlem myopathy 1a | Enrichment | COL6A1, COL6A2, COL6A3 | 4.76 |
| 50 | Intervertebral disc disease | Enrichment | COL11A1, COL9A2, COL9A3 | 4.76 |
| 51 | Epidermolysis bullosa | Enrichment | COL7A1, ITGA6, LAMB3 | 4.68 |
| 52 | Lung cancer susceptibility 3 | Enrichment | ACTA2, BRAF, EGFR, KRAS | 4.49 |
| 53 | Nonsyndromic hearing loss | Enrichment | ACTG1, COL11A2, MYH14, MYO15A, MYO3A, MYO6, MYO7A, RDX | 4.47 |
| 54 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | ITGA2, ITGA2B, ITGB3 | 4.39 |
| 55 | Amelogenesis imperfecta, type ia | Enrichment | COL17A1, LAMB3 | 4.19 |
| 56 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 4.19 |
| 57 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 4.19 |
| 58 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL11A2, COL2A1 | 4.19 |
| 59 | Loeys-dietz syndrome 2 | Enrichment | TGFBR1, TGFBR2 | 4.19 |
| 60 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL11A2, COL2A1 | 4.19 |
| 61 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 4.19 |
| 62 | Fibrochondrogenesis | Enrichment | COL11A1, COL11A2 | 4.19 |
| 63 | Aortic dissection | Enrichment | COL3A1, FBN1 | 4.19 |
| 64 | Stickler syndrome, type ii | Enrichment | COL11A1, COL1A1 | 4.19 |
| 65 | Loeys-dietz syndrome 4 | Enrichment | TGFB2, TGFB3 | 4.19 |
| 66 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 4.19 |
| 67 | X-linked diffuse leiomyomatosis-alport syndrome | Enrichment | COL4A5, COL4A6 | 4.19 |
| 68 | Pilomyxoid astrocytoma | Enrichment | BRAF, KRAS, RAF1 | 4.06 |
| 69 | Non-syndromic genetic deafness | Enrichment | ACTG1, MYH14, MYO15A, MYO3A, MYO6, MYO7A, RDX | 4.03 |
| 70 | Familial thoracic aortic aneurysm and dissection | Enrichment | COL3A1, FBN1, MYH11, MYLK | 4.02 |
| 71 | Renal hypodysplasia/aplasia 3 | Enrichment | FRAS1, FREM1, FREM2 | 3.98 |
| 72 | Cutis laxa | Enrichment | COL5A1, EFEMP1, EFEMP2 | 3.98 |
| 73 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | ACTG2, MYH11, MYLK | 3.95 |
| 74 | Diaphragmatic hernia, congenital | Enrichment | FBN1, FRAS1, FREM2 | 3.87 |
| 75 | Multiple sclerosis | Enrichment | ITGB4, ITPR1, LAMA5, LAMB1 | 3.86 |
| 76 | Ras-associated autoimmune leukoproliferative disorder | Enrichment | KRAS, NRAS | 3.78 |
| 77 | Recessive dystrophic epidermolysis bullosa | Enrichment | COL7A1, MMP1 | 3.78 |
| 78 | Metaphyseal anadysplasia | Enrichment | MMP13, MMP9 | 3.78 |
| 79 | Localized junctional epidermolysis bullosa, non-herlitz type | Enrichment | COL17A1, ITGB4 | 3.78 |
| 80 | Contractural arachnodactyly, congenital | Enrichment | FBN1, FBN2 | 3.72 |
| 81 | Hematuria, benign familial, 1 | Enrichment | COL4A3, COL4A4 | 3.72 |
| 82 | Telecanthus | Enrichment | COL11A1, COL5A2 | 3.72 |
| 83 | Ehlers-danlos syndrome, classic type, 2 | Enrichment | COL5A1, COL5A2 | 3.72 |
| 84 | Loeys-dietz syndrome 1 | Enrichment | TGFBR1, TGFBR2 | 3.72 |
| 85 | High bone mass osteogenesis imperfecta | Enrichment | COL1A1, COL1A2 | 3.72 |
| 86 | Pulmonic stenosis | Enrichment | BRAF, SOS1 | 3.72 |
| 87 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 3.72 |
| 88 | Amelogenesis imperfecta, type ie | Enrichment | COL17A1, ITGB6, LAMB3 | 3.63 |
| 89 | Visceral myopathy 1 | Enrichment | ACTG2, MYH11, MYLK | 3.57 |
| 90 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | GNAS, PRKAR1A | 3.56 |
| 91 | Melanoma | Enrichment | BRAF, FBN1, PTEN | 3.53 |
| 92 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 3.42 |
| 93 | Brain small vessel disease 1 with or without ocular anomalies | Enrichment | COL4A1, COL4A2 | 3.42 |
| 94 | Alport syndrome 2, autosomal recessive | Enrichment | COL4A3, COL4A4 | 3.42 |
| 95 | Macular dystrophy, vitelliform, 3 | Enrichment | IMPG1, IMPG2 | 3.42 |
| 96 | Aortic aneurysm | Enrichment | FBN1, TGFBR1 | 3.42 |
| 97 | Autosomal recessive alport syndrome | Enrichment | COL4A3, COL4A4 | 3.42 |
| 98 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 3.42 |
| 99 | Lennox-gastaut syndrome | Enrichment | CACNA1A, DNM1, MAPK10 | 3.38 |
| 100 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | ITGB3, STAT3 | 3.31 |
| 101 | Bleeding disorder, platelet-type, 16 | Enrichment | ITGA2B, ITGB3 | 3.31 |
| 102 | Large congenital melanocytic nevus | Enrichment | HRAS, NRAS | 3.31 |
| 103 | Lip and oral cavity carcinoma | Enrichment | BRAF, EGFR, HRAS | 3.28 |
| 104 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | ITGA6, ITGB4, MYO6 | 3.28 |
| 105 | Hereditary retinal dystrophy | Enrichment | COL11A2, COL18A1, COL2A1, COL9A1, EFEMP1, IMPG1, IMPG2, LAMA1, VCAN | 3.27 |
| 106 | Fundus dystrophy | Enrichment | COL11A2, COL18A1, COL2A1, COL9A1, EFEMP1, IMPG1, IMPG2, LAMA1, VCAN | 3.27 |
| 107 | Primary hyperaldosteronism | Enrichment | BRAF, CACNA1H, GNAS | 3.21 |
| 108 | Macular dystrophy, vitelliform, 2 | Enrichment | IMPG1, IMPG2 | 3.20 |
| 109 | Retinal detachment | Enrichment | COL2A1, COL9A3 | 3.20 |
| 110 | Familial porencephaly | Enrichment | COL4A1, COL4A2 | 3.20 |
| 111 | Familial cerebral saccular aneurysm | Enrichment | COL3A1, TGFBR3 | 3.20 |
| 112 | Bladder cancer | Enrichment | EGFR, HRAS, KRAS, PTEN | 3.19 |
| 113 | Differentiated thyroid carcinoma | Enrichment | BRAF, HRAS, KRAS, NRAS | 3.19 |
| 114 | Rare genetic deafness | Enrichment | ACTG1, COL11A2, COL4A5, DIAPH1, MYH9, MYO15A, MYO6, MYO7A, RDX | 3.18 |
| 115 | Aortic aneurysm, familial thoracic 1 | Enrichment | COL3A1, FBN1, MYH11, MYLK | 3.17 |
| 116 | Osteoporosis | Enrichment | COL1A1, COL1A2, SRC | 3.16 |
| 117 | Isolated macular dystrophy | Enrichment | COL4A5, IMPG1, ITGA4 | 3.16 |
| 118 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | GNA11, PIK3R1 | 3.09 |
| 119 | Anastomosing haemangioma | Enrichment | GNA11, GNA14 | 3.09 |
| 120 | Dilated cardiomyopathy | Enrichment | ACTA1, BRAF, FBN1, LAMA2, RAF1, VCL | 3.08 |
| 121 | Congenital myopathy 4a, autosomal dominant | Enrichment | ACTA1, ITGA7, MYH7, MYL2 | 3.05 |
| 122 | Scoliosis | Enrichment | COL2A1, EFEMP1, FBN1 | 3.04 |
| 123 | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis | Enrichment | CLDN1, CLDN16 | 3.03 |
| 124 | Hypomagnesemia 5, renal, with or without ocular involvement | Enrichment | CLDN16, CLDN19 | 3.03 |
| 125 | Renal hypomagnesemia 5 with ocular involvement | Enrichment | CLDN16, CLDN19 | 3.03 |
| 126 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 3.03 |
| 127 | Fraser syndrome 1 | Enrichment | FRAS1, FREM2 | 3.03 |
| 128 | Hemorrhage, intracerebral | Enrichment | COL4A1, COL4A2 | 3.03 |
| 129 | Lung cancer | Enrichment | ACTA2, BRAF, EGFR, KRAS | 3.02 |
| 130 | Chronic myelogenous leukemia, bcr-abl1 positive | Enrichment | KRAS, NRAS | 3.01 |
| 131 | Pediatric systemic lupus erythematosus | Enrichment | SPP1, STAT4 | 3.01 |
| 132 | Cerebral palsy | Enrichment | CACNA1A, CACNA1C, COL4A1, COL4A2, GNB1 | 2.98 |
| 133 | Congenital stationary night blindness | Enrichment | CACNA1F, CACNA2D4, GNAT1, GNB3 | 2.98 |
| 134 | Noonan syndrome with multiple lentigines | Enrichment | BRAF, RAF1 | 2.95 |
| 135 | Knobloch syndrome | Enrichment | COL18A1, PAK2 | 2.95 |
| 136 | Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures | Enrichment | CACNA1A, CACNA1C | 2.92 |
| 137 | Tethered spinal cord syndrome | Enrichment | BRAF, CREBBP | 2.92 |
| 138 | Cakut | Enrichment | ACTG1, COL4A1, FRAS1, FREM2 | 2.92 |
| 139 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 2.88 |
| 140 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1, CALM2, CALM3 | 2.85 |
| 141 | Heart, malformation of | Enrichment | COL11A2, COL2A1, MAPK1 | 2.83 |
| 142 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | ADCY1, CLDN14, COL11A2, MYH9, MYO15A, MYO3A, MYO6, MYO7A, RDX | 2.80 |
| 143 | Orthostatic intolerance | Enrichment | COL5A1, FBN1 | 2.76 |
| 144 | Knobloch syndrome 1 | Enrichment | COL18A1, PAK2 | 2.73 |
| 145 | Arteriovenous malformations of the brain | Enrichment | BRAF, EGFR, KRAS | 2.67 |
| 146 | Auriculocondylar syndrome 1 | Enrichment | GNAI3, PLCB4 | 2.63 |
| 147 | Achromatopsia 4 | Enrichment | GNAI3, GNAT2 | 2.63 |
| 148 | Breast adenocarcinoma | Enrichment | AKT1, KRAS | 2.62 |
| 149 | Cone-rod dystrophy 6 | Enrichment | CACNA1F, CACNA2D4, GNAT2 | 2.60 |
| 150 | Granulomatous disease, chronic, autosomal recessive, 2 | Enrichment | NCF1, NCF2 | 2.56 |
| 151 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2 | 2.56 |
| 152 | Cowden syndrome 1 | Enrichment | EGFR, PTEN | 2.56 |
| 153 | Lung squamous cell carcinoma | Enrichment | EGFR, KRAS | 2.56 |
| 154 | Ovarian cancer | Enrichment | AKT1, EGFR, HMMR, KRAS, PTEN, RRAS2 | 2.55 |
| 155 | Stroke, ischemic | Enrichment | F2, FBN1, PRKCH | 2.54 |
| 156 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CACNA1I, CACNG2, CAMK2A, CAMK2B, GNB1 | 2.49 |
| 157 | Sensorineural hearing loss | Enrichment | CLDN14, COL11A2, COL9A1, MYO15A, MYO3A, MYO7A | 2.49 |
| 158 | Myelofibrosis | Enrichment | JAK2, SRC | 2.48 |
| 159 | Glanzmann thrombasthenia 1 | Enrichment | ITGA2B, ITGB3 | 2.48 |
| 160 | Leukemia, chronic myeloid | Enrichment | KRAS, NRAS | 2.48 |
| 161 | Pectus excavatum | Enrichment | FBN1, TGFBR1 | 2.47 |
| 162 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2 | 2.47 |
| 163 | Presynaptic congenital myasthenic syndromes | Enrichment | COL13A1, LAMA5 | 2.47 |
| 164 | Squamous cell carcinoma, head and neck | Enrichment | EGFR, PTEN | 2.42 |
| 165 | Capillary malformation-arteriovenous malformation 1 | Enrichment | KRAS, MAP2K1 | 2.42 |
| 166 | Gallbladder cancer | Enrichment | BRAF, KRAS | 2.42 |
| 167 | Thrombocytopenia | Enrichment | ITGA2B, ITGB3, SRC, WAS | 2.36 |
| 168 | Renal hypodysplasia/aplasia 1 | Enrichment | FRAS1, ITGA8 | 2.36 |
| 169 | Microcephaly | Enrichment | ACTB, ACTG1, COL4A1, COL7A1, GNB1, MAPK1, PAK3 | 2.35 |
| 170 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2 | 2.33 |
| 171 | Amelogenesis imperfecta | Enrichment | COL17A1, LAMB3 | 2.33 |
| 172 | Chronic kidney disease | Enrichment | COL4A4, COL4A5 | 2.33 |
| 173 | Congenital muscular dystrophy | Enrichment | CAPN3, LAMA2 | 2.30 |
| 174 | Eye disease | Enrichment | CACNA1F, CACNA2D4, GNAT2, IMPG2 | 2.29 |
| 175 | Granulomatous disease, chronic, x-linked | Enrichment | CYBB, NCF1 | 2.27 |
| 176 | Carney complex variant | Enrichment | MYH8, PRKAR1A | 2.27 |
| 177 | Mitral valve insufficiency | Enrichment | FBN1, MYH11 | 2.27 |
| 178 | Familial sick sinus syndrome | Enrichment | GNB2, MYH6 | 2.27 |
| 179 | Cataract | Enrichment | COL18A1, COL5A1 | 2.26 |
| 180 | Ear malformation | Enrichment | COL11A2, MYO15A, MYO6, MYO7A | 2.25 |
| 181 | Melanoma, uveal | Enrichment | GNA11, PLCB4 | 2.24 |
| 182 | Osteogenesis imperfecta, type iii | Enrichment | COL1A1, COL1A2 | 2.20 |
| 183 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1 | 2.19 |
| 184 | Cowden syndrome | Enrichment | AKT1, PTEN | 2.19 |
| 185 | Autosomal dominant macrothrombocytopenia | Enrichment | ITGA2B, ITGB3 | 2.16 |
| 186 | Hypertension | Enrichment | COL4A4, COL4A5 | 2.15 |
| 187 | Colorectal cancer | Enrichment | AKT1, BRAF, NRAS, PIK3R1, SRC | 2.14 |
| 188 | Spastic paraplegia 4, autosomal dominant | Enrichment | COL3A1, GNAS | 2.14 |
| 189 | Brugada syndrome 1 | Enrichment | CACNA2D1, FBN1 | 2.10 |
| 190 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1 | 2.10 |
| 191 | Stickler syndrome, type i | Enrichment | COL2A1 | 2.09 |
| 192 | Bladder diverticulum | Enrichment | EFEMP1 | 2.09 |
| 193 | Cryptophthalmos, unilateral or bilateral, isolated | Enrichment | FREM2 | 2.09 |
| 194 | Short stature and advanced bone age with or without early-onset osteoarthritis and/or osteochondritis dissecans | Enrichment | ACAN | 2.09 |
| 195 | Ectopia lentis 1, isolated, autosomal dominant | Enrichment | FBN1 | 2.09 |
| 196 | Epidermolysis bullosa dystrophica, pretibial | Enrichment | COL7A1 | 2.09 |
| 197 | Epidermolysis bullosa dystrophica, autosomal dominant | Enrichment | COL7A1 | 2.09 |
| 198 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 2.09 |
| 199 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 2.09 |
| 200 | Epidermolysis bullosa dystrophica, autosomal recessive | Enrichment | COL7A1 | 2.09 |
| 201 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 2.09 |
| 202 | Alport syndrome 1, x-linked | Enrichment | COL4A5 | 2.09 |
| 203 | Deafness, autosomal recessive 53 | Enrichment | COL11A2 | 2.09 |
| 204 | Cornelia de lange syndrome 3 with or without midline brain defects | Enrichment | SMC3 | 2.09 |
| 205 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 2.09 |
| 206 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 2.09 |
| 207 | Czech dysplasia | Enrichment | COL2A1 | 2.09 |
| 208 | Nail disorder, nonsyndromic congenital, 8 | Enrichment | COL7A1 | 2.09 |
| 209 | Coronary heart disease 7 | Enrichment | CD36 | 2.09 |
| 210 | Glaucoma 1, open angle, h | Enrichment | EFEMP1 | 2.09 |
| 211 | Corneal dystrophy, posterior polymorphous, 2 | Enrichment | COL8A2 | 2.09 |
| 212 | Marshall syndrome | Enrichment | COL11A1 | 2.09 |
| 213 | Kniest dysplasia | Enrichment | COL2A1 | 2.09 |
| 214 | Cardiomyopathy, dilated, 1jj | Enrichment | LAMA4 | 2.09 |
| 215 | Transient bullous dermolysis of the newborn | Enrichment | COL7A1 | 2.09 |
| 216 | Corneal dystrophy, fuchs endothelial, 1 | Enrichment | COL8A2 | 2.09 |
| 217 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 2.09 |
| 218 | Epidermolysis bullosa with congenital localized absence of skin and deformity of nails | Enrichment | COL7A1 | 2.09 |
| 219 | Multiple self-healing squamous epithelioma | Enrichment | TGFBR1 | 2.09 |
| 220 | Fibrochondrogenesis 1 | Enrichment | COL11A1 | 2.09 |
| 221 | Lipoid proteinosis of urbach and wiethe | Enrichment | ECM1 | 2.09 |
| 222 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 2.09 |
| 223 | Lissencephaly 5 | Enrichment | LAMB1 | 2.09 |
| 224 | Weill-marchesani syndrome 2 | Enrichment | FBN1 | 2.09 |
| 225 | Retinitis pigmentosa 56 | Enrichment | IMPG2 | 2.09 |
| 226 | Deafness, autosomal dominant 56 | Enrichment | TNC | 2.09 |
| 227 | Geleophysic dysplasia 2 | Enrichment | FBN1 | 2.09 |
| 228 | Protrusio acetabuli | Enrichment | FBN1 | 2.09 |
| 229 | Acrogeria, gottron type | Enrichment | COL3A1 | 2.09 |
| 230 | Epiphyseal dysplasia, multiple, 6 | Enrichment | COL9A1 | 2.09 |
| 231 | Achondrogenesis, type ii | Enrichment | COL2A1 | 2.09 |
| 232 | Macular degeneration, early-onset | Enrichment | FBN2 | 2.09 |
| 233 | Macular dystrophy, vitelliform, 4 | Enrichment | IMPG1 | 2.09 |
| 234 | Fraser syndrome 2 | Enrichment | FREM2 | 2.09 |
| 235 | Nephrotic syndrome, type 26 | Enrichment | LAMA5 | 2.09 |
| 236 | Myasthenic syndrome, congenital, 19 | Enrichment | COL13A1 | 2.09 |
| 237 | Deafness, x-linked 6 | Enrichment | COL4A6 | 2.09 |
| 238 | Epiphyseal dysplasia, multiple, 2 | Enrichment | COL9A2 | 2.09 |
| 239 | Ullrich congenital muscular dystrophy 1b | Enrichment | COL6A2 | 2.09 |
| 240 | Cutis laxa, autosomal recessive, type id | Enrichment | EFEMP1 | 2.09 |
| 241 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 2.09 |
| 242 | Complete cryptophthalmia | Enrichment | FREM2 | 2.09 |
| 243 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 2.09 |
| 244 | Myosclerosis, autosomal recessive | Enrichment | COL6A2 | 2.09 |
| 245 | Porencephaly | Enrichment | COL4A1 | 2.09 |
| 246 | Ullrich congenital muscular dystrophy 1c | Enrichment | COL6A3 | 2.09 |
| 247 | Deafness, autosomal dominant 37 | Enrichment | COL11A1 | 2.09 |
| 248 | Lymphoplasmacytic lymphoma | Enrichment | FBN1 | 2.09 |
| 249 | Epiphyseal dysplasia, multiple, 3 | Enrichment | COL9A3 | 2.09 |
| 250 | Spondyloepimetaphyseal dysplasia, aggrecan type | Enrichment | ACAN | 2.09 |
| 251 | Deafness, autosomal dominant 13 | Enrichment | COL11A2 | 2.09 |
| 252 | Microvascular complications of diabetes 1 | Enrichment | VEGFA | 2.09 |
| 253 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 2.09 |
| 254 | Spondyloepiphyseal dysplasia, kimberley type | Enrichment | ACAN | 2.09 |
| 255 | Epidermolysis bullosa pruriginosa | Enrichment | COL7A1 | 2.09 |
| 256 | Platelet glycoprotein iv deficiency | Enrichment | CD36 | 2.09 |
| 257 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 2.09 |
| 258 | Colorectal cancer, hereditary nonpolyposis, type 6 | Enrichment | TGFBR2 | 2.09 |
| 259 | Stickler syndrome, type iv | Enrichment | COL9A1 | 2.09 |
| 260 | Cortical malformations, occipital | Enrichment | LAMC3 | 2.09 |
| 261 | Fibrochondrogenesis 2 | Enrichment | COL11A2 | 2.09 |
| 262 | Dystonia 27 | Enrichment | COL6A3 | 2.09 |
| 263 | Thyroid gland disease | Enrichment | COL7A1 | 2.09 |
| 264 | Stickler syndrome, type v | Enrichment | COL9A2 | 2.09 |
| 265 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 2.09 |
| 266 | Macular dystrophy, vitelliform, 5 | Enrichment | IMPG2 | 2.09 |
| 267 | Qualitative or quantitative defects of collagen 6 | Enrichment | COL6A2 | 2.09 |
| 268 | Bent bone dysplasia syndrome 2 | Enrichment | LAMA5 | 2.09 |
| 269 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 2.09 |
| 270 | Recessive dystrophic epidermolysis bullosa-generalized other | Enrichment | COL7A1 | 2.09 |
| 271 | Tufted angioma of skin | Enrichment | KDR | 2.09 |
| 272 | Asphyxia neonatorum | Enrichment | COL1A1 | 2.09 |
| 273 | Bethlem myopathy 1b | Enrichment | COL6A2 | 2.09 |
| 274 | Fibrosis of extraocular muscles, congenital, 5 | Enrichment | COL25A1 | 2.09 |
| 275 | Late-onset junctional epidermolysis bullosa | Enrichment | COL17A1 | 2.09 |
| 276 | Col4a1-related disorders | Enrichment | COL4A1 | 2.09 |
| 277 | Occipital pachygyria and polymicrogyria | Enrichment | LAMC3 | 2.09 |
| 278 | Bethlem myopathy 1c | Enrichment | COL6A3 | 2.09 |
| 279 | Retinal lattice degeneration | Enrichment | COL9A3 | 2.09 |
| 280 | Anus disease | Enrichment | FREM2 | 2.09 |
| 281 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 2.09 |
| 282 | Col4a1 or col4a2-related cerebral small vessel disease | Enrichment | COL4A1 | 2.09 |
| 283 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 2.09 |
| 284 | Hypochondrogenesis | Enrichment | COL2A1 | 2.09 |
| 285 | X-linked alport syndrome | Enrichment | COL4A5 | 2.09 |
| 286 | Pneumothorax | Enrichment | COL5A1 | 2.09 |
| 287 | Localized dystrophic epidermolysis bullosa, acral form | Enrichment | COL7A1 | 2.09 |
| 288 | Osteochondritis dissecans | Enrichment | ACAN | 2.09 |
| 289 | Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome | Enrichment | COL11A1 | 2.09 |
| 290 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 2.09 |
| 291 | Cystic lymphangioma | Enrichment | COL11A2 | 2.09 |
| 292 | Abdominal aortic aneurysm | Enrichment | COL3A1 | 2.09 |
| 293 | Lethal arteriopathy syndrome due to fibulin-4 deficiency | Enrichment | EFEMP2 | 2.09 |
| 294 | Neonatal marfan syndrome | Enrichment | FBN1 | 2.09 |
| 295 | Recessive dystrophic epidermolysis bullosa inversa | Enrichment | COL7A1 | 2.09 |
| 296 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 2.09 |
| 297 | Lama5-related multisystemic syndrome | Enrichment | LAMA5 | 2.09 |
| 298 | Short stature-advanced bone age-early-onset osteoarthritis syndrome | Enrichment | ACAN | 2.09 |
| 299 | Cryptophthalmia | Enrichment | FREM2 | 2.09 |
| 300 | Generalized dominant dystrophic epidermolysis bullosa | Enrichment | COL7A1 | 2.09 |
| 301 | Laminin subunit alpha 2-related muscular dystrophy | Enrichment | LAMA2 | 2.09 |
| 302 | Hypertelorism | Enrichment | COL11A1, COL1A1, ELN | 2.08 |
| 303 | Congenital myopathy 3 with rigid spine | Enrichment | ACTA1, MYH7 | 2.06 |
| 304 | Congenital ptosis | Enrichment | COL25A1, MYH10 | 2.06 |
| 305 | Non-immune hydrops fetalis | Enrichment | ACTA1, HRAS, KRAS | 2.05 |
| 306 | Beckwith-wiedemann syndrome | Enrichment | COL6A1, COL7A1 | 2.05 |
| 307 | Ellis-van creveld syndrome | Enrichment | PRKACA, PRKACB | 2.04 |
| 308 | Focal segmental glomerulosclerosis | Enrichment | COL4A4, COL4A5 | 1.96 |
| 309 | Meningioma | Enrichment | AKT1, PTEN | 1.94 |
| 310 | Acute promyelocytic leukemia | Enrichment | STAT3, STAT5B | 1.93 |
| 311 | Chromosome 1p36 deletion syndrome | Enrichment | HSPG2, MMP23B | 1.93 |
| 312 | Long qt syndrome 1 | Enrichment | CALM1, CALM2, CALM3, ITPR3 | 1.90 |
| 313 | Proteus syndrome | Enrichment | AKT1 | 1.89 |
| 314 | Oculoectodermal syndrome | Enrichment | KRAS | 1.89 |
| 315 | Systemic lupus erythematosus 6 | Enrichment | ITGAM | 1.89 |
| 316 | Cavitary optic disc anomalies | Enrichment | MMP19 | 1.89 |
| 317 | Melanosis, neurocutaneous | Enrichment | NRAS | 1.89 |
| 318 | Noonan syndrome 6 | Enrichment | NRAS | 1.89 |
| 319 | Ataxia-oculomotor apraxia 3 | Enrichment | PIK3R5 | 1.89 |
| 320 | Noonan syndrome 11 | Enrichment | MRAS | 1.89 |
| 321 | Angioedema, hereditary, 4 | Enrichment | PLG | 1.89 |
| 322 | Pseudo-torch syndrome 3 | Enrichment | STAT2 | 1.89 |
| 323 | Noonan syndrome 13 | Enrichment | MAPK1 | 1.89 |
| 324 | Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | Enrichment | STAT5B | 1.89 |
| 325 | Hyper-ige syndrome 6, autosomal dominant, with recurrent infections | Enrichment | STAT6 | 1.89 |
| 326 | Disabling pansclerotic morphea of childhood | Enrichment | STAT4 | 1.89 |
| 327 | Short syndrome | Enrichment | PIK3R1 | 1.89 |
| 328 | Fetomaternal alloimmune thrombocytopenia 2 | Enrichment | ITGA2B | 1.89 |
| 329 | T-cell large granular lymphocyte leukemia | Enrichment | STAT3 | 1.89 |
| 330 | Systemic lupus erythematosus 11 | Enrichment | STAT4 | 1.89 |
| 331 | Plasminogen activator inhibitor-1 deficiency | Enrichment | SERPINE1 | 1.89 |
| 332 | Cardiofaciocutaneous syndrome 2 | Enrichment | KRAS | 1.89 |
| 333 | Heterotaxy, visceral, 7, autosomal | Enrichment | MMP21 | 1.89 |
| 334 | Coronary heart disease 6 | Enrichment | MMP3 | 1.89 |
| 335 | Immunodeficiency 31a | Enrichment | STAT1 | 1.89 |
| 336 | Immunodeficiency 36 with lymphoproliferation | Enrichment | PIK3R1 | 1.89 |
| 337 | Cowden syndrome 6 | Enrichment | AKT1 | 1.89 |
| 338 | Agammaglobulinemia 7, autosomal recessive | Enrichment | PIK3R1 | 1.89 |
| 339 | Immunodeficiency 31b | Enrichment | STAT1 | 1.89 |
| 340 | Autoimmune disease, multisystem, infantile-onset, 1 | Enrichment | STAT3 | 1.89 |
| 341 | Thrombocytopenia 6 | Enrichment | SRC | 1.89 |
| 342 | T-b+ severe combined immunodeficiency due to jak3 deficiency | Enrichment | JAK3 | 1.89 |
| 343 | Amelogenesis imperfecta, type ih | Enrichment | ITGB6 | 1.89 |
| 344 | Stat3-related early-onset multisystem autoimmune disease | Enrichment | STAT3 | 1.89 |
| 345 | Congenital pulmonary airway malformation | Enrichment | KRAS | 1.89 |
| 346 | Fetomaternal alloimmune thrombocytopenia 3 | Enrichment | ITGA2 | 1.89 |
| 347 | Immune dysregulation, neurodevelopmental defects, and colitis | Enrichment | ITGAV | 1.89 |
| 348 | Congenital plasminogen activator inhibitor type 1 deficiency | Enrichment | SERPINE1 | 1.89 |
| 349 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 1.89 |
| 350 | Chronic lymphoproliferative disorder of natural killer cells | Enrichment | STAT3 | 1.89 |
| 351 | Mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiency | Enrichment | JAK1 | 1.89 |
| 352 | Neurocutaneous melanocytosis | Enrichment | NRAS | 1.89 |
| 353 | Moyamoya disease 1 | Enrichment | ACTA2, DIAPH1 | 1.89 |
| 354 | Intestinal pseudo-obstruction | Enrichment | ACTG2, MYH11 | 1.89 |
| 355 | Adrenocortical carcinoma | Enrichment | CTNNB1, PRKAR1A | 1.89 |
| 356 | Typical nemaline myopathy | Enrichment | ACTA1, CFL2 | 1.89 |
| 357 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | CACNA1C, RAC1 | 1.88 |
| 358 | Systemic lupus erythematosus | Enrichment | ITGAM, SPP1, STAT4 | 1.86 |
| 359 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 1.86 |
| 360 | Vacterl association with hydrocephalus | Enrichment | PTEN | 1.86 |
| 361 | Thrombocytopenia 1 | Enrichment | WAS | 1.86 |
| 362 | Intellectual developmental disorder, x-linked 30 | Enrichment | PAK3 | 1.86 |
| 363 | Pallister-killian syndrome | Enrichment | ARAF | 1.86 |
| 364 | Noonan syndrome 5 | Enrichment | RAF1 | 1.86 |
| 365 | Hypomagnesemia 4, renal | Enrichment | EGF | 1.86 |
| 366 | Noonan syndrome 4 | Enrichment | SOS1 | 1.86 |
| 367 | Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis | Enrichment | RAC2 | 1.86 |
| 368 | Congenital myopathy 2a, typical, autosomal dominant | Enrichment | ACTA1 | 1.86 |
| 369 | Melorheostosis, isolated | Enrichment | MAP2K1 | 1.86 |
| 370 | Noonan syndrome 7 | Enrichment | BRAF | 1.86 |
| 371 | Leopard syndrome 3 | Enrichment | BRAF | 1.86 |
| 372 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 1.86 |
| 373 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 1.86 |
| 374 | Noonan syndrome 9 | Enrichment | SOS2 | 1.86 |
| 375 | Myopathy, scapulohumeroperoneal | Enrichment | ACTA1 | 1.86 |
| 376 | Vitreoretinopathy, neovascular inflammatory | Enrichment | CAPN5 | 1.86 |
| 377 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 | Enrichment | ACTG2 | 1.86 |
| 378 | Knobloch syndrome 2 | Enrichment | PAK2 | 1.86 |
| 379 | Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies | Enrichment | RAC3 | 1.86 |
| 380 | Pulmonary hypertension, primary, 6 | Enrichment | CAPNS1 | 1.86 |
| 381 | Intellectual developmental disorder with macrocephaly, seizures, and speech delay | Enrichment | PAK1 | 1.86 |
| 382 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 1.86 |
| 383 | Immune dysregulation, autoimmunity, and autoinflammation | Enrichment | PLCG1 | 1.86 |
| 384 | Intellectual developmental disorder, x-linked 46 | Enrichment | ARHGEF6 | 1.86 |
| 385 | Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia | Enrichment | RAC2 | 1.86 |
| 386 | Papillary tumor of the pineal region | Enrichment | PTEN | 1.86 |
| 387 | Cardiomyopathy, dilated, 1w | Enrichment | VCL | 1.86 |
| 388 | Lymphangioma | Enrichment | BRAF | 1.86 |
| 389 | Phace association | Enrichment | BRAF | 1.86 |
| 390 | Becker nevus syndrome | Enrichment | ACTB | 1.86 |
| 391 | Melorheostosis | Enrichment | MAP2K1 | 1.86 |
| 392 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 1.86 |
| 393 | Visceral neuropathy, familial, 3, autosomal dominant | Enrichment | ACTG2 | 1.86 |
| 394 | Leopard syndrome 2 | Enrichment | RAF1 | 1.86 |
| 395 | Cardiomyopathy, familial hypertrophic, 15 | Enrichment | VCL | 1.86 |
| 396 | Congenital myopathy 2b, severe infantile, autosomal recessive | Enrichment | ACTA1 | 1.86 |
| 397 | Cardiofaciocutaneous syndrome 4 | Enrichment | MAP2K2 | 1.86 |
| 398 | Autoinflammation, antibody deficiency, and immune dysregulation | Enrichment | PLCG2 | 1.86 |
| 399 | Autosomal dominant familial visceral neuropathy | Enrichment | ACTG2 | 1.86 |
| 400 | Glioma susceptibility 2 | Enrichment | PTEN | 1.86 |
| 401 | Familial cold autoinflammatory syndrome 3 | Enrichment | PLCG2 | 1.86 |
| 402 | Was-related disorders | Enrichment | WAS | 1.86 |
| 403 | Congenital myopathy 2c, severe infantile, autosomal dominant | Enrichment | ACTA1 | 1.86 |
| 404 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 1.86 |
| 405 | Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia | Enrichment | RAC2 | 1.86 |
| 406 | Trigonitis | Enrichment | RAF1 | 1.86 |
| 407 | Polycystic ovary syndrome | Enrichment | CAPN10 | 1.86 |
| 408 | Baraitser-winter syndrome | Enrichment | ACTB | 1.86 |
| 409 | Progressive muscular atrophy | Enrichment | CAPN3 | 1.86 |
| 410 | Zebra body myopathy | Enrichment | ACTA1 | 1.86 |
| 411 | Infantile lad-like disease due to rac2 deficiency | Enrichment | RAC2 | 1.86 |
| 412 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 1.86 |
| 413 | Capillary leak syndrome | Enrichment | TLN1 | 1.86 |
| 414 | Reticular dysgenesis-like severe combined immunodeficiency | Enrichment | RAC2 | 1.86 |
| 415 | Syringocystadenoma papilliferum | Enrichment | BRAF | 1.86 |
| 416 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 1.86 |
| 417 | Ganglioglioma | Enrichment | BRAF | 1.86 |
| 418 | Nongerminomatous germ cell tumor | Enrichment | BRAF | 1.86 |
| 419 | Phace syndrome | Enrichment | BRAF | 1.86 |
| 420 | Qualitative or quantitative defects of calpain | Enrichment | CAPN3 | 1.86 |
| 421 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | Enrichment | PTEN | 1.86 |
| 422 | Actin-accumulation myopathy | Enrichment | ACTA1 | 1.86 |
| 423 | Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom | Enrichment | RAC1 | 1.86 |
| 424 | Classic hairy cell leukemia | Enrichment | BRAF | 1.86 |
| 425 | Myopathic intestinal pseudoobstruction | Enrichment | ACTG2 | 1.86 |
| 426 | Rac2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome | Enrichment | RAC2 | 1.86 |
| 427 | Egf-related primary hypomagnesemia with intellectual disability | Enrichment | EGF | 1.86 |
| 428 | Temporomandibular joint anomaly | Enrichment | DOCK1 | 1.86 |
| 429 | Actg2 visceral myopathy | Enrichment | ACTG2 | 1.86 |
| 430 | Long qt syndrome | Enrichment | CALM1, CALM2, CTNNA3, MYH6 | 1.85 |
| 431 | Brittle bone disorder | Enrichment | COL1A1, COL1A2 | 1.84 |
| 432 | Leukemia, acute myeloid | Enrichment | JAK2, KRAS, NRAS | 1.83 |
| 433 | Brugada syndrome | Enrichment | CACNA1C, CACNA2D1, CACNB2 | 1.83 |
| 434 | Acromicric dysplasia | Enrichment | FBN1 | 1.80 |
| 435 | Ehlers-danlos syndrome, vascular type | Enrichment | COL3A1 | 1.80 |
| 436 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1 | 1.80 |
| 437 | Amelogenesis imperfecta, type ib | Enrichment | COL17A1 | 1.80 |
| 438 | Cutis laxa, autosomal dominant 1 | Enrichment | ELN | 1.80 |
| 439 | Ehlers-danlos syndrome, hypermobility type | Enrichment | COL3A1 | 1.80 |
| 440 | Wagner vitreoretinopathy | Enrichment | VCAN | 1.80 |
| 441 | Metaphyseal chondrodysplasia, schmid type | Enrichment | COL10A1 | 1.80 |
| 442 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.80 |
| 443 | Manitoba oculotrichoanal syndrome | Enrichment | FREM1 | 1.80 |
| 444 | Epidermolysis bullosa, junctional 2c, laryngoonychocutaneous | Enrichment | LAMA3 | 1.80 |
| 445 | Bruck syndrome 1 | Enrichment | COL1A2 | 1.80 |
| 446 | Stiff skin syndrome | Enrichment | FBN1 | 1.80 |
| 447 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | Enrichment | PRG4 | 1.80 |
| 448 | Myasthenic syndrome, congenital, 5 | Enrichment | LAMB2 | 1.80 |
| 449 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1 | 1.80 |
| 450 | Bifid nose with or without anorectal and renal anomalies | Enrichment | FREM1 | 1.80 |
| 451 | Doyne honeycomb retinal dystrophy | Enrichment | EFEMP1 | 1.80 |
| 452 | Microvascular complications of diabetes 5 | Enrichment | TGFBR2 | 1.80 |
| 453 | Legg-calve-perthes disease | Enrichment | COL2A1 | 1.80 |
| 454 | Lissencephaly 1 | Enrichment | LAMB1 | 1.80 |
| 455 | Epithelial recurrent erosion dystrophy | Enrichment | COL17A1 | 1.80 |
| 456 | Specific language impairment 5 | Enrichment | COL4A4 | 1.80 |
| 457 | Beaulieu-boycott-innes syndrome | Enrichment | FBN1 | 1.80 |
| 458 | Angioma, tufted | Enrichment | KDR | 1.80 |
| 459 | Pierson syndrome | Enrichment | LAMB2 | 1.80 |
| 460 | Schwartz-jampel syndrome, type 1 | Enrichment | HSPG2 | 1.80 |
| 461 | Supravalvular aortic stenosis | Enrichment | ELN | 1.80 |
| 462 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | Enrichment | COL4A2 | 1.80 |
| 463 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 1.80 |
| 464 | Epidermolysis bullosa, junctional 3b, severe | Enrichment | LAMC2 | 1.80 |
| 465 | Epidermolysis bullosa, junctional 3a, intermediate | Enrichment | LAMC2 | 1.80 |
| 466 | Epidermolysis bullosa, junctional 4, intermediate | Enrichment | COL17A1 | 1.80 |
| 467 | Stickler syndrome, type vi | Enrichment | COL9A3 | 1.80 |
| 468 | Fibromuscular dysplasia, multifocal | Enrichment | COL5A1 | 1.80 |
| 469 | Epidermolysis bullosa, junctional 2a, intermediate | Enrichment | LAMA3 | 1.80 |
| 470 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | Enrichment | COL3A1 | 1.80 |
| 471 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.80 |
| 472 | Nephrotic syndrome, type 5, with or without ocular abnormalities | Enrichment | LAMB2 | 1.80 |
| 473 | Marfanoid-progeroid-lipodystrophy syndrome | Enrichment | FBN1 | 1.80 |
| 474 | Optic disk drusen | Enrichment | EFEMP1 | 1.80 |
| 475 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.80 |
| 476 | Glomerulonephritis | Enrichment | COL4A4 | 1.80 |
| 477 | Metaphyseal anadysplasia 2 | Enrichment | MMP9 | 1.80 |
| 478 | Glaucoma, primary closed-angle | Enrichment | COL18A1 | 1.80 |
| 479 | Trigonocephaly 2 | Enrichment | FREM1 | 1.80 |
| 480 | Steel syndrome | Enrichment | COL27A1 | 1.80 |
| 481 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 1.80 |
| 482 | Epidermolysis bullosa, junctional 2b, severe | Enrichment | LAMA3 | 1.80 |
| 483 | Cataract 16, multiple types | Enrichment | COL12A1 | 1.80 |
| 484 | Interfrontal craniofaciosynostosis | Enrichment | FREM1 | 1.80 |
| 485 | Wagner disease | Enrichment | VCAN | 1.80 |
| 486 | Dentinogenesis imperfecta | Enrichment | COL1A2 | 1.80 |
| 487 | Epidermolysis bullosa dystrophica | Enrichment | COL7A1 | 1.80 |
| 488 | Lens subluxation | Enrichment | FBN1 | 1.80 |
| 489 | Hypocalciuric hypercalcemia, familial, type ii | Enrichment | GNA11 | 1.78 |
| 490 | Acrodysostosis 1 with or without hormone resistance | Enrichment | PRKAR1A | 1.78 |
| 491 | Pseudohypoparathyroidism, type ic | Enrichment | GNAS | 1.78 |
| 492 | Lipodystrophy, congenital generalized, type 3 | Enrichment | CAV1 | 1.78 |
| 493 | Carney complex, type 1 | Enrichment | PRKAR1A | 1.78 |
| 494 | Osseous heteroplasia, progressive | Enrichment | GNAS | 1.78 |
| 495 | Amyloidosis, finnish type | Enrichment | GSN | 1.78 |
| 496 | Amyotrophic lateral sclerosis 18 | Enrichment | PFN1 | 1.78 |
| 497 | Deafness, autosomal recessive 44 | Enrichment | ADCY1 | 1.78 |
| 498 | Pulmonary hypertension, primary, 3 | Enrichment | CAV1 | 1.78 |
| 499 | Acth-independent macronodular adrenal hyperplasia 1 | Enrichment | GNAS | 1.78 |
| 500 | Neurodevelopmental disorder with hypotonia and dysmorphic facies | Enrichment | GNB2 | 1.78 |
| 501 | Pituitary adenoma 3, multiple types | Enrichment | GNAS | 1.78 |
| 502 | Cardioacrofacial dysplasia 2 | Enrichment | PRKACB | 1.78 |
| 503 | Myxoma, intracardiac | Enrichment | PRKAR1A | 1.78 |
| 504 | Lipodystrophy, familial partial, type 7 | Enrichment | CAV1 | 1.78 |
| 505 | Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia | Enrichment | GNB5 | 1.78 |
| 506 | Hypocalcemia, autosomal dominant 2 | Enrichment | GNA11 | 1.78 |
| 507 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 1.78 |
| 508 | Charcot-marie-tooth disease, dominant intermediate f | Enrichment | GNB4 | 1.78 |
| 509 | Disorders of gnas inactivation | Enrichment | GNAS | 1.78 |
| 510 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 1.78 |
| 511 | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | Enrichment | RHOA | 1.78 |
| 512 | Takenouchi-kosaki syndrome | Enrichment | CDC42 | 1.78 |
| 513 | Intellectual developmental disorder, autosomal dominant 42 | Enrichment | GNB1 | 1.78 |
| 514 | Noonan syndrome-like disorder with loose anagen hair 2 | Enrichment | PPP1CB | 1.78 |
| 515 | Sick sinus syndrome 4 | Enrichment | GNB2 | 1.78 |
| 516 | Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies | Enrichment | RHOA | 1.78 |
| 517 | Prkar1b-related neurodegenerative dementia with intermediate filaments | Enrichment | PRKAR1B | 1.78 |
| 518 | Cerebral cavernous malformations 5 | Enrichment | MAP3K3 | 1.78 |
| 519 | Nocarh syndrome | Enrichment | CDC42 | 1.78 |
| 520 | Monostotic fibrous dysplasia | Enrichment | GNAS | 1.78 |
| 521 | Phakomatosis cesiomarmorata | Enrichment | GNA11 | 1.78 |
| 522 | Verrucous hemangioma | Enrichment | MAP3K3 | 1.78 |
| 523 | Kaposiform hemangioendothelioma | Enrichment | GNA14 | 1.78 |
| 524 | Mazabraud syndrome | Enrichment | GNAS | 1.78 |
| 525 | Anhidrosis, isolated, with normal sweat glands | Enrichment | ITPR2 | 1.70 |
| 526 | Thyrotoxic periodic paralysis 1 | Enrichment | CACNA1S | 1.70 |
| 527 | Epilepsy, idiopathic generalized 9 | Enrichment | CACNB4 | 1.70 |
| 528 | Brugada syndrome 4 | Enrichment | CACNB2 | 1.70 |
| 529 | Charcot-marie-tooth disease, dominant intermediate b | Enrichment | DNM2 | 1.70 |
| 530 | Dyskinesia with orofacial involvement, autosomal dominant | Enrichment | ADCY5 | 1.70 |
| 531 | Neurodevelopmental disorder with involuntary movements | Enrichment | GNAO1 | 1.70 |
| 532 | Episodic ataxia, type 5 | Enrichment | CACNB4 | 1.70 |
| 533 | Hypogonadotropic hypogonadism 23 with or without anosmia | Enrichment | LHB | 1.70 |
| 534 | Autoimmune lymphoproliferative syndrome, type iii | Enrichment | PRKCD | 1.70 |
| 535 | Ventricular tachycardia, familial | Enrichment | GNAI2 | 1.70 |
| 536 | Spondylometaphyseal dysplasia with corneal dystrophy | Enrichment | PLCB3 | 1.70 |
| 537 | Neurodevelopmental disorder with hyperkinetic movements and dyskinesia | Enrichment | ADCY5 | 1.70 |
| 538 | Charcot-marie-tooth disease, demyelinating, type 1j | Enrichment | ITPR3 | 1.70 |
| 539 | Neurodevelopmental disorder with speech impairment and with or without seizures | Enrichment | CACNA1I | 1.70 |
| 540 | Intellectual developmental disorder, autosomal recessive 63 | Enrichment | CAMK2A | 1.70 |
| 541 | Congenital myopathy 18 | Enrichment | CACNA1S | 1.70 |
| 542 | Intellectual developmental disorder, autosomal dominant 54 | Enrichment | CAMK2B | 1.70 |
| 543 | Auriculocondylar syndrome 2a | Enrichment | PLCB4 | 1.70 |
| 544 | Cone-rod dystrophy, x-linked, 3 | Enrichment | CACNA1F | 1.70 |
| 545 | Retinal cone dystrophy 4 | Enrichment | CACNA2D4 | 1.70 |
| 546 | Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities | Enrichment | GNAI1 | 1.70 |
| 547 | Developmental and epileptic encephalopathy 17 | Enrichment | GNAO1 | 1.70 |
| 548 | Primary aldosteronism, seizures, and neurologic abnormalities | Enrichment | CACNA1D | 1.70 |
| 549 | Dyskinesia with orofacial involvement, autosomal recessive | Enrichment | ADCY5 | 1.70 |
| 550 | Brugada syndrome 3 | Enrichment | CACNA1C | 1.70 |
| 551 | Epilepsy, childhood absence 6 | Enrichment | CACNA1H | 1.70 |
| 552 | Malignant hyperthermia 5 | Enrichment | CACNA1S | 1.70 |
| 553 | Spinocerebellar ataxia 14 | Enrichment | PRKCG | 1.70 |
| 554 | Night blindness, congenital stationary, autosomal dominant 3 | Enrichment | GNAT1 | 1.70 |
| 555 | Intellectual developmental disorder, autosomal dominant 10 | Enrichment | CACNG2 | 1.70 |
| 556 | Lethal congenital contracture syndrome 5 | Enrichment | DNM2 | 1.70 |
| 557 | Sinoatrial node dysfunction and deafness | Enrichment | CACNA1D | 1.70 |
| 558 | Dystonia 25 | Enrichment | GNAL | 1.70 |
| 559 | Hypogonadotropic hypogonadism 12 with or without anosmia | Enrichment | GNRH1 | 1.70 |
| 560 | Night blindness, congenital stationary, type 1g | Enrichment | GNAT1 | 1.70 |
| 561 | Spinocerebellar ataxia 42 | Enrichment | CACNA1G | 1.70 |
| 562 | Developmental and epileptic encephalopathy 110 | Enrichment | CACNA2D1 | 1.70 |
| 563 | Congenital heart defects and ectodermal dysplasia | Enrichment | PRKD1 | 1.70 |
| 564 | Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits | Enrichment | CACNA1G | 1.70 |
| 565 | Developmental and epileptic encephalopathy 69 | Enrichment | CACNA1E | 1.70 |
| 566 | Hyperaldosteronism, familial, type iv | Enrichment | CACNA1H | 1.70 |
| 567 | Menke-hennekam syndrome 1 | Enrichment | CREBBP | 1.70 |
| 568 | Intellectual developmental disorder, autosomal dominant 53 | Enrichment | CAMK2A | 1.70 |
| 569 | Auriculocondylar syndrome 2b | Enrichment | PLCB4 | 1.70 |
| 570 | Intellectual developmental disorder, autosomal dominant 59 | Enrichment | CAMK2G | 1.70 |
| 571 | Isolated gonadotropin-releasing hormone deficiency | Enrichment | GNRHR | 1.70 |
| 572 | Rubinstein-taybi syndrome due to 16p13.3 microdeletion | Enrichment | CREBBP | 1.70 |
| 573 | Autosomal dominant charcot-marie-tooth disease type 2m | Enrichment | DNM2 | 1.70 |
| 574 | Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy | Enrichment | ITPR3 | 1.70 |
| 575 | Conn's syndrome | Enrichment | CACNA1H | 1.70 |
| 576 | Sporadic hemiplegic migraine | Enrichment | CACNA1A | 1.70 |
| 577 | Atypical timothy syndrome | Enrichment | CACNA1C | 1.70 |
| 578 | Aldosterone-producing adenoma with seizures and neurological abnormalities | Enrichment | CACNA1D | 1.70 |
| 579 | Menke-hennekam syndrome | Enrichment | CREBBP | 1.70 |
| 580 | Timothy syndrome type 2 | Enrichment | CACNA1C | 1.70 |
| 581 | Gnao1-related disorder | Enrichment | GNAO1 | 1.70 |
| 582 | Periodic paralysis with transient compartment-like syndrome | Enrichment | CACNA1S | 1.70 |
| 583 | Malignant epithelial tumor of salivary glands | Enrichment | PRKD1 | 1.70 |
| 584 | Timothy syndrome type 1 | Enrichment | CACNA1C | 1.70 |
| 585 | Cacna1c-related disorders | Enrichment | CACNA1C | 1.70 |
| 586 | Benign paroxysmal torticollis of infancy | Enrichment | CACNA1A | 1.70 |
| 587 | Creatine phosphokinase, elevated serum | Enrichment | CAPN3, LAMA2 | 1.70 |
| 588 | Isolated elevated serum creatine phosphokinase levels | Enrichment | CAPN3, LAMA2 | 1.70 |
| 589 | Rhabdomyosarcoma | Enrichment | HRAS, PTEN | 1.70 |
| 590 | Breast cancer | Enrichment | AKT1, HMMR, KRAS, PTEN | 1.69 |
| 591 | Hereditary breast carcinoma | Enrichment | AKT1, KRAS, PTEN | 1.64 |
| 592 | Achondroplasia | Enrichment | FBN1 | 1.62 |
| 593 | Retinal arteries, tortuosity of | Enrichment | COL4A1 | 1.62 |
| 594 | Palmoplantar keratoderma, punctate type ia | Enrichment | COL14A1 | 1.62 |
| 595 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.62 |
| 596 | Megalocornea | Enrichment | COL11A1 | 1.62 |
| 597 | Dyssegmental dysplasia, silverman-handmaker type | Enrichment | HSPG2 | 1.62 |
| 598 | Nail disorder, nonsyndromic congenital, 4 | Enrichment | COL7A1 | 1.62 |
| 599 | Hypophosphatasia, infantile | Enrichment | COL11A2 | 1.62 |
| 600 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.62 |
| 601 | Muscular dystrophy, congenital merosin-deficient, 1a | Enrichment | LAMA2 | 1.62 |
| 602 | Caffey disease | Enrichment | COL1A1 | 1.62 |
| 603 | Brain small vessel disease 2 | Enrichment | COL4A2 | 1.62 |
| 604 | Ullrich congenital muscular dystrophy 2 | Enrichment | COL12A1 | 1.62 |
| 605 | Bethlem myopathy 2 | Enrichment | COL12A1 | 1.62 |
| 606 | Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | Enrichment | COL4A1 | 1.62 |
| 607 | Pilarowski-bjornsson syndrome | Enrichment | COL4A3 | 1.62 |
| 608 | Alport syndrome 3b, autosomal recessive | Enrichment | COL4A3 | 1.62 |
| 609 | Weill-marchesani syndrome 1 | Enrichment | FBN1 | 1.62 |
| 610 | Cutis laxa, autosomal recessive, type ib | Enrichment | EFEMP2 | 1.62 |
| 611 | Autosomal recessive cutis laxa type i | Enrichment | EFEMP2 | 1.62 |
| 612 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.62 |
| 613 | Isolated ectopia lentis | Enrichment | FBN1 | 1.62 |
| 614 | Autosomal dominant cutis laxa | Enrichment | ELN | 1.62 |
| 615 | Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps | Enrichment | COL4A1 | 1.62 |
| 616 | Hematuria, benign familial, 2 | Enrichment | COL4A3 | 1.62 |
| 617 | Geleophysic dysplasia | Enrichment | FBN1 | 1.62 |
| 618 | Multiple epiphyseal dysplasia | Enrichment | COL2A1 | 1.62 |
| 619 | Familial drusen | Enrichment | EFEMP1 | 1.62 |
| 620 | Hyperpigmentation of the skin | Enrichment | COL7A1 | 1.62 |
| 621 | Lama2-related muscular dystrophy | Enrichment | LAMA2 | 1.62 |
| 622 | Stargardt disease 1 | Enrichment | COL18A1, COL2A1 | 1.62 |
| 623 | Leukocyte adhesion deficiency, type i | Enrichment | ITGB2 | 1.59 |
| 624 | Scoliosis, isolated 1 | Enrichment | MAPK7 | 1.59 |
| 625 | Costello syndrome | Enrichment | HRAS | 1.59 |
| 626 | Hemangiopericytoma, malignant | Enrichment | STAT6 | 1.59 |
| 627 | Metaphyseal dysplasia, spahr type | Enrichment | MMP13 | 1.59 |
| 628 | Plasminogen deficiency, type i | Enrichment | PLG | 1.59 |
| 629 | Growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive | Enrichment | STAT5B | 1.59 |
| 630 | Spondyloepimetaphyseal dysplasia, missouri type | Enrichment | MMP13 | 1.59 |
| 631 | Quebec platelet disorder | Enrichment | PLAU | 1.59 |
| 632 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | Enrichment | PIK3R5 | 1.59 |
| 633 | Amelogenesis imperfecta, hypomaturation type, iia2 | Enrichment | MMP20 | 1.59 |
| 634 | Leukocyte adhesion deficiency, type iii | Enrichment | ITGB2 | 1.59 |
| 635 | Encephalocraniocutaneous lipomatosis | Enrichment | KRAS | 1.59 |
| 636 | Thrombocythemia 3 | Enrichment | JAK2 | 1.59 |
| 637 | Immunodeficiency 31c | Enrichment | STAT1 | 1.59 |
| 638 | Epidermolysis bullosa, junctional 5a, intermediate | Enrichment | ITGB4 | 1.59 |
| 639 | Noonan syndrome 12 | Enrichment | RRAS2 | 1.59 |
| 640 | Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome | Enrichment | ITGA3 | 1.59 |
| 641 | Preterm premature rupture of the membranes | Enrichment | MMP8 | 1.59 |
| 642 | Autoinflammation, immune dysregulation, and eosinophilia | Enrichment | JAK1 | 1.59 |
| 643 | Hereditary angioedema | Enrichment | PLG | 1.59 |
| 644 | Polycythemia | Enrichment | JAK2 | 1.59 |
| 645 | Hypereosinophilic syndrome | Enrichment | JAK2 | 1.59 |
| 646 | Laron syndrome with immunodeficiency | Enrichment | STAT5B | 1.59 |
| 647 | Wooly hair nevus | Enrichment | HRAS | 1.59 |
| 648 | Undetermined early-onset epileptic encephalopathy | Enrichment | CACNA1A, CACNA1B, CACNA2D1, DNM1 | 1.58 |
| 649 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 1.56 |
| 650 | Neutropenia, severe congenital, x-linked | Enrichment | WAS | 1.56 |
| 651 | Wiskott-aldrich syndrome | Enrichment | WAS | 1.56 |
| 652 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.56 |
| 653 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 1.56 |
| 654 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.56 |
| 655 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.56 |
| 656 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 1.56 |
| 657 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.56 |
| 658 | Spastic paraplegia 76, autosomal recessive | Enrichment | CAPN1 | 1.56 |
| 659 | Intellectual developmental disorder, autosomal dominant 48 | Enrichment | RAC1 | 1.56 |
| 660 | Vacterl with hydrocephalus | Enrichment | PTEN | 1.56 |
| 661 | Juvenile polyposis of infancy | Enrichment | PTEN | 1.56 |
| 662 | Tafro syndrome | Enrichment | MAP2K2 | 1.56 |
| 663 | Intestinal obstruction | Enrichment | ACTG2 | 1.56 |
| 664 | Diffuse large b-cell lymphoma | Enrichment | BRAF, PTEN | 1.55 |
| 665 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | MYH7, NCF1 | 1.54 |
| 666 | Genetic steroid-resistant nephrotic syndrome | Enrichment | COL4A3, LAMA5 | 1.52 |
| 667 | Hypomagnesemia 3, renal | Enrichment | CLDN16 | 1.51 |
| 668 | Pseudo-torch syndrome 1 | Enrichment | OCLN | 1.51 |
| 669 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a | Enrichment | MYH3 | 1.51 |
| 670 | Granulomatous disease, chronic, autosomal recessive, 4 | Enrichment | CYBA | 1.51 |
| 671 | Immunodeficiency 50 | Enrichment | MSN | 1.51 |
| 672 | Immunodeficiency 34 | Enrichment | CYBB | 1.51 |
| 673 | Deafness, autosomal recessive 2 | Enrichment | MYO7A | 1.51 |
| 674 | Deafness, autosomal recessive 24 | Enrichment | RDX | 1.51 |
| 675 | Deafness, autosomal dominant 17 | Enrichment | MYH9 | 1.51 |
| 676 | Deafness, autosomal dominant 48 | Enrichment | MYO1A | 1.51 |
| 677 | Macular dystrophy, patterned, 2 | Enrichment | CTNNA1 | 1.51 |
| 678 | Cardiomyopathy, familial hypertrophic, 8 | Enrichment | MYL3 | 1.51 |
| 679 | Prothrombin deficiency, congenital | Enrichment | F2 | 1.51 |
| 680 | Deafness, autosomal dominant 22 | Enrichment | MYO6 | 1.51 |
| 681 | Deafness, autosomal dominant 1, with or without thrombocytopenia | Enrichment | DIAPH1 | 1.51 |
| 682 | Polycystic lung disease | Enrichment | CCR2 | 1.51 |
| 683 | Cardiomyopathy, dilated, 1ee | Enrichment | MYH6 | 1.51 |
| 684 | Sick sinus syndrome 3 | Enrichment | MYH6 | 1.51 |
| 685 | Griscelli syndrome, type 1 | Enrichment | MYO5A | 1.51 |
| 686 | Elejalde neuroectodermal melanolysosomal syndrome | Enrichment | MYO5A | 1.51 |
| 687 | Whim syndrome 1 | Enrichment | CXCR4 | 1.51 |
| 688 | Transient erythroblastopenia of childhood | Enrichment | TEC | 1.51 |
| 689 | Arrhythmogenic right ventricular dysplasia, familial, 13 | Enrichment | CTNNA3 | 1.51 |
| 690 | Immunodeficiency 62 | Enrichment | ARHGEF1 | 1.51 |
| 691 | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Enrichment | JAM2 | 1.51 |
| 692 | Neurodevelopmental disorder with absent language and variable seizures | Enrichment | WASF1 | 1.51 |
| 693 | Helix syndrome | Enrichment | CLDN10 | 1.51 |
| 694 | Deafness, autosomal dominant 4a | Enrichment | MYH14 | 1.51 |
| 695 | Cortical dysplasia, complex, with other brain malformations 9 | Enrichment | CTNNA2 | 1.51 |
| 696 | Deafness, autosomal recessive 116 | Enrichment | CLDN9 | 1.51 |
| 697 | Azoospermia, obstructive, with nephrolithiasis | Enrichment | CLDN2 | 1.51 |
| 698 | Deafness, autosomal recessive 37 | Enrichment | MYO6 | 1.51 |
| 699 | Isolated growth hormone deficiency type iii | Enrichment | BTK | 1.51 |
| 700 | Diarrhea 15, congenital | Enrichment | MYO1A | 1.51 |
| 701 | Atrial fibrillation, familial, 18 | Enrichment | MYL4 | 1.51 |
| 702 | Nemaline myopathy 7 | Enrichment | CFL2 | 1.51 |
| 703 | Deafness, autosomal dominant 11 | Enrichment | MYO7A | 1.51 |
| 704 | Deafness, autosomal recessive 30 | Enrichment | MYO3A | 1.51 |
| 705 | Lymphoproliferative syndrome 1 | Enrichment | ITK | 1.51 |
| 706 | Celiac disease 4 | Enrichment | MYO9B | 1.51 |
| 707 | Cardiomyopathy, familial hypertrophic, 14 | Enrichment | MYH6 | 1.51 |
| 708 | Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies | Enrichment | RAP1B | 1.51 |
| 709 | Long qt syndrome 16 | Enrichment | CALM3 | 1.51 |
| 710 | Peripheral neuropathy, myopathy, hoarseness, and hearing loss | Enrichment | MYH14 | 1.51 |
| 711 | Hemorrhagic destruction of the brain, subependymal calcification, and cataracts | Enrichment | JAM3 | 1.51 |
| 712 | Type 1 diabetes mellitus 22 | Enrichment | CCR5 | 1.51 |
| 713 | Focal segmental glomerulosclerosis 6 | Enrichment | MYO1E | 1.51 |
| 714 | Pregnancy loss, recurrent 2 | Enrichment | F2 | 1.51 |
| 715 | Leukodystrophy, hypomyelinating, 22 | Enrichment | CLDN11 | 1.51 |
| 716 | Seizures, cortical blindness, and microcephaly syndrome | Enrichment | DIAPH1 | 1.51 |
| 717 | Diaph1-related sensorineural hearing loss-thrombocytopenia syndrome | Enrichment | DIAPH1 | 1.51 |
| 718 | Deafness, autosomal dominant 90 | Enrichment | MYO3A | 1.51 |
| 719 | Myasthenic syndrome, congenital, 24, presynaptic | Enrichment | MYO9A | 1.51 |
| 720 | Congenital myopathy 14 | Enrichment | MYL1 | 1.51 |
| 721 | Primary hypomagnesemia | Enrichment | CLDN16 | 1.51 |
| 722 | Immunodeficiency 129 | Enrichment | RHOH | 1.51 |
| 723 | Whim syndrome 2 | Enrichment | CXCR2 | 1.51 |
| 724 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.51 |
| 725 | Long qt syndrome 15 | Enrichment | CALM2 | 1.51 |
| 726 | Autoinflammation with pulmonary and cutaneous vasculitis | Enrichment | HCK | 1.51 |
| 727 | Usher syndrome type 1b | Enrichment | MYO7A | 1.51 |
| 728 | T-cell immunodeficiency with epidermodysplasia verruciformis | Enrichment | RHOH | 1.51 |
| 729 | Klippel-feil syndrome | Enrichment | MYO18B | 1.51 |
| 730 | Prothrombin deficiency | Enrichment | F2 | 1.51 |
| 731 | Autosomal dominant nonsyndromic hearing loss 17 | Enrichment | MYH9 | 1.51 |
| 732 | Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome | Enrichment | MYO6 | 1.51 |
| 733 | Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency | Enrichment | CXCR2 | 1.51 |
| 734 | Autosomal dominant nonsyndromic hearing loss 22 | Enrichment | MYO6 | 1.51 |
| 735 | Porencephaly-microcephaly-bilateral congenital cataract syndrome | Enrichment | JAM3 | 1.51 |
| 736 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.51 |
| 737 | Retinitis pigmentosa 91 | Enrichment | IMPG1 | 1.50 |
| 738 | Phenylketonuria | Enrichment | COL1A1 | 1.50 |
| 739 | Schizencephaly | Enrichment | COL4A1 | 1.50 |
| 740 | Arthrogryposis multiplex congenita 2, neurogenic type | Enrichment | COL25A1 | 1.50 |
| 741 | Congenital generalized lipodystrophy | Enrichment | FOS | 1.50 |
| 742 | Weill-marchesani syndrome | Enrichment | FBN1 | 1.50 |
| 743 | Blood platelet disease | Enrichment | CD36 | 1.50 |
| 744 | Corneal dystrophy | Enrichment | COL17A1 | 1.50 |
| 745 | Epidermolytic hyperkeratosis | Enrichment | COL7A1 | 1.50 |
| 746 | Cerebral malaria | Enrichment | CD36 | 1.50 |
| 747 | Rare x-linked non-syndromic sensorineural deafness type dfn | Enrichment | COL4A6 | 1.50 |
| 748 | Cleft palate, isolated | Enrichment | COL11A1, GNB1 | 1.50 |
| 749 | Dandy-walker syndrome | Enrichment | BRAF, PPP1CB | 1.50 |
| 750 | Dystonia | Enrichment | CAMK2B, GNAL, GNB1 | 1.48 |
| 751 | Burkitt lymphoma | Enrichment | MYC | 1.48 |
| 752 | Pseudohypoparathyroidism, type ia | Enrichment | GNAS | 1.48 |
| 753 | Amelogenesis imperfecta, type ig | Enrichment | PRKAR1A | 1.48 |
| 754 | Cutis marmorata telangiectatica congenita | Enrichment | GNA11 | 1.48 |
| 755 | Lethal congenital contracture syndrome 3 | Enrichment | PIP5K1C | 1.48 |
| 756 | Pseudopseudohypoparathyroidism | Enrichment | GNAS | 1.48 |
| 757 | Neutrophilia, hereditary | Enrichment | PIP4K2B | 1.48 |
| 758 | Bleeding disorder, platelet-type, 19 | Enrichment | PRKACG | 1.48 |
| 759 | Night blindness, congenital stationary, type 1h | Enrichment | GNB3 | 1.48 |
| 760 | Neutropenia, severe congenital, 7, autosomal recessive | Enrichment | PIP4K2B | 1.48 |
| 761 | Genitourinary and/or brain malformation syndrome | Enrichment | PPP1R12A | 1.48 |
| 762 | Marbach-schaaf neurodevelopmental syndrome | Enrichment | PRKAR1B | 1.48 |
| 763 | Usher syndrome, type iv | Enrichment | PRKAR1A | 1.48 |
| 764 | Noonan syndrome-like disorder with loose anagen hair | Enrichment | PPP1CB | 1.48 |
| 765 | Autosomal dominant hypocalcemia | Enrichment | GNA11 | 1.48 |
| 766 | Acrodysostosis | Enrichment | PRKAR1A | 1.48 |
| 767 | Pseudohypoparathyroidism | Enrichment | GNAS | 1.48 |
| 768 | Body mass index quantitative trait locus 19 | Enrichment | ADCY3 | 1.48 |
| 769 | Severe congenital neutropenia 7 | Enrichment | PIP4K2B | 1.48 |
| 770 | Fibrolamellar carcinoma | Enrichment | PRKACA | 1.48 |
| 771 | Intellectual developmental disorder, autosomal dominant 60, with seizures | Enrichment | PIP5K1A | 1.48 |
| 772 | Immune system disease | Enrichment | CDC42 | 1.48 |
| 773 | Ciliary dyskinesia, primary, 18 | Enrichment | PRKAR1B | 1.48 |
| 774 | B-lymphoblastic leukemia/lymphoma with hyperdiploidy | Enrichment | PIP4K2A | 1.48 |
| 775 | Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia | Enrichment | GNB5 | 1.48 |
| 776 | Isolated primary pigmented nodular adrenocortical disease | Enrichment | PRKAR1A | 1.48 |
| 777 | Acth-independent macronodular adrenal hyperplasia | Enrichment | GNAS | 1.48 |
| 778 | Cerebral visual impairment | Enrichment | GNB1 | 1.48 |
| 779 | Phakomatosis cesioflammea | Enrichment | GNA11 | 1.48 |
| 780 | Developmental and epileptic encephalopathy | Enrichment | CACNA1E, CACNA2D2, GNAO1 | 1.45 |
| 781 | Corpus callosum, agenesis of | Enrichment | COL4A1, CREBBP | 1.45 |
| 782 | Anterior segment dysgenesis | Enrichment | COL4A1, ITPR1 | 1.45 |
| 783 | Isolated corpus callosum agenesis | Enrichment | COL4A1, CREBBP | 1.45 |
| 784 | Rare genetic intellectual disability | Enrichment | CREBBP, GNAO1 | 1.45 |
| 785 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | COL4A1, CREBBP | 1.45 |
| 786 | Nephrocalcinosis | Enrichment | CLDN16, CLDN19 | 1.45 |
| 787 | Nemaline myopathy | Enrichment | ACTA1, MYO18B | 1.45 |
| 788 | Nephrolithiasis | Enrichment | CLDN16, CLDN19 | 1.45 |
| 789 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | MYH6, MYH7, MYH7B | 1.45 |
| 790 | Familial isolated dilated cardiomyopathy | Enrichment | LAMA4, RAF1, VCL | 1.43 |
| 791 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency | Enrichment | JAK3 | 1.42 |
| 792 | Angioedema, hereditary, 1 | Enrichment | PLG | 1.42 |
| 793 | Polycythemia vera | Enrichment | JAK2 | 1.42 |
| 794 | Multicentric osteolysis, nodulosis, and arthropathy | Enrichment | MMP2 | 1.42 |
| 795 | Muscular dystrophy, congenital, due to integrin alpha-7 deficiency | Enrichment | ITGA7 | 1.42 |
| 796 | Immunodeficiency 14a with lymphoproliferation, autosomal dominant | Enrichment | PIK3R1 | 1.42 |
| 797 | Epidermolysis bullosa, junctional 6, with pyloric atresia | Enrichment | ITGA6 | 1.42 |
| 798 | Hyper ige syndrome | Enrichment | STAT3 | 1.42 |
| 799 | Immunodeficiency 14 | Enrichment | PIK3R1 | 1.42 |
| 800 | Immunodeficiency 44 | Enrichment | STAT2 | 1.42 |
| 801 | Spermatocytoma | Enrichment | HRAS | 1.42 |
| 802 | Bleeding disorder, platelet-type, 24 | Enrichment | ITGB3 | 1.42 |
| 803 | Alopecia - intellectual disability syndrome | Enrichment | ITGB6 | 1.42 |
| 804 | Distal arthrogryposis | Enrichment | ACTA1, COL25A1, MYH3, MYL11 | 1.41 |
| 805 | Polycystic liver disease 1 with or without kidney cysts | Enrichment | FBN1 | 1.40 |
| 806 | Epidermolytic hyperkeratosis 1 | Enrichment | COL7A1 | 1.40 |
| 807 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 1.40 |
| 808 | Arthrogryposis, renal dysfunction, and cholestasis 1 | Enrichment | FBN1 | 1.40 |
| 809 | Goldberg-shprintzen syndrome | Enrichment | FBN1 | 1.40 |
| 810 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | LAMA2 | 1.40 |
| 811 | Fuchs' endothelial dystrophy | Enrichment | COL8A2 | 1.40 |
| 812 | Polycystic liver disease 1 | Enrichment | FBN1 | 1.40 |
| 813 | Night blindness | Enrichment | EFEMP1 | 1.40 |
| 814 | Juvenile glaucoma | Enrichment | EFEMP1 | 1.40 |
| 815 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 1.40 |
| 816 | Histiocytoid hemangioma | Enrichment | FOS | 1.40 |
| 817 | Spinocerebellar ataxia 29 | Enrichment | ITPR1 | 1.40 |
| 818 | Pituitary adenoma 4, acth-secreting | Enrichment | GNAI2 | 1.40 |
| 819 | Thumb deformity | Enrichment | CREBBP | 1.40 |
| 820 | Hypogonadotropic hypogonadism 24 with or without anosmia | Enrichment | FSHB | 1.40 |
| 821 | Timothy syndrome | Enrichment | CACNA1C | 1.40 |
| 822 | Night blindness, congenital stationary, type 2a | Enrichment | CACNA1F | 1.40 |
| 823 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 1.40 |
| 824 | Alternating hemiplegia of childhood 1 | Enrichment | CACNA1A | 1.40 |
| 825 | Lethal congenital contracture syndrome 8 | Enrichment | ADCY6 | 1.40 |
| 826 | Immunodeficiency, common variable, 12, with autoimmunity | Enrichment | NFKB1 | 1.40 |
| 827 | Long qt syndrome 8 | Enrichment | CACNA1C | 1.40 |
| 828 | Acute myeloid leukemia with kat6a-crebbp fusion | Enrichment | CREBBP | 1.40 |
| 829 | Ocular melanoma | Enrichment | PLCB4 | 1.40 |
| 830 | Hypopituitarism | Enrichment | GNAI2 | 1.40 |
| 831 | Congenital disorder of glycosylation, type iw, autosomal dominant | Enrichment | CACNA1D | 1.40 |
| 832 | Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements | Enrichment | CACNA1B | 1.40 |
| 833 | Common variable immunodeficiency 12 | Enrichment | NFKB1 | 1.40 |
| 834 | Progressive bulbar palsy | Enrichment | CACNA1A | 1.40 |
| 835 | Hereditary breast ovarian cancer syndrome | Enrichment | BCAR1, KRAS, PTEN | 1.39 |
| 836 | Type 1 diabetes mellitus 2 | Enrichment | CAPN10 | 1.39 |
| 837 | Ataxia-telangiectasia | Enrichment | BRAF | 1.39 |
| 838 | Nuchal bleb, familial | Enrichment | SOS1 | 1.39 |
| 839 | Neonatal nephrocutaneous inflammatory syndrome | Enrichment | EGFR | 1.39 |
| 840 | Muscular dystrophy, limb-girdle, autosomal dominant 4 | Enrichment | CAPN3 | 1.39 |
| 841 | Autosomal recessive limb-girdle muscular dystrophy type 2a | Enrichment | CAPN3 | 1.39 |
| 842 | Laryngeal squamous cell carcinoma | Enrichment | PTEN | 1.39 |
| 843 | Neonatal inflammatory skin and bowel disease | Enrichment | EGFR | 1.39 |
| 844 | Hypertrophic cardiomyopathy | Enrichment | MYH7, MYH7B, MYL2, MYL3 | 1.38 |
| 845 | Myeloma, multiple | Enrichment | BRAF, KRAS, PIK3R2 | 1.37 |
| 846 | Muscular dystrophy | Enrichment | CAPN3, COL6A2 | 1.36 |
| 847 | Atrial septal defect 1 | Enrichment | TGFB2 | 1.33 |
| 848 | Spondyloepiphyseal dysplasia with congenital joint dislocations | Enrichment | ACAN | 1.33 |
| 849 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.33 |
| 850 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | COL8A2 | 1.33 |
| 851 | Hemangioma, capillary infantile | Enrichment | KDR | 1.33 |
| 852 | Wiedemann-steiner syndrome | Enrichment | SMC3 | 1.33 |
| 853 | Anterior segment dysgenesis 5 | Enrichment | COL4A1 | 1.33 |
| 854 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 1.33 |
| 855 | Congenital fibrosis of the extraocular muscles | Enrichment | COL25A1 | 1.33 |
| 856 | Pain disorder | Enrichment | COL5A1 | 1.33 |
| 857 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 1.33 |
| 858 | Cone-rod dystrophy 2 | Enrichment | CACNA1F, CACNA2D4, IMPG2, ITGA4 | 1.32 |
| 859 | Aortic aneurysm, familial thoracic 7 | Enrichment | MYLK | 1.31 |
| 860 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | MYC | 1.31 |
| 861 | Cushing syndrome due to bilateral macronodular adrenocortical disease | Enrichment | GNAS | 1.31 |
| 862 | Hydrops fetalis, nonimmune | Enrichment | ACTA1, HRAS | 1.30 |
| 863 | Normosmic congenital hypogonadotropic hypogonadism | Enrichment | GNRH1, GNRHR | 1.30 |
| 864 | Amelogenesis imperfecta, type iiia | Enrichment | ITGB6 | 1.30 |
| 865 | Erythrocytosis, familial, 1 | Enrichment | JAK2 | 1.30 |
| 866 | Diffuse gastric and lobular breast cancer syndrome | Enrichment | KRAS | 1.30 |
| 867 | Budd-chiari syndrome | Enrichment | JAK2 | 1.30 |
| 868 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | PIK3R2 | 1.30 |
| 869 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.30 |
| 870 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | PIK3R2 | 1.30 |
| 871 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | ITGB4 | 1.30 |
| 872 | Retinitis pigmentosa 26 | Enrichment | ITGA4 | 1.30 |
| 873 | Lung sarcomatoid carcinoma | Enrichment | KRAS | 1.30 |
| 874 | Pilocytic astrocytoma | Enrichment | KRAS | 1.30 |
| 875 | Epidermolytic nevus | Enrichment | HRAS | 1.30 |
| 876 | Adenosine deaminase deficiency | Enrichment | JAK3 | 1.30 |
| 877 | Pseudomyogenic hemangioendothelioma | Enrichment | SERPINE1 | 1.30 |
| 878 | Severe covid-19 | Enrichment | ITGAV, JAK3 | 1.27 |
| 879 | Nemaline myopathy 2 | Enrichment | ACTA1 | 1.27 |
| 880 | Thyroid cancer, nonmedullary, 1 | Enrichment | BRAF | 1.27 |
| 881 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.27 |
| 882 | Neurofibromatosis-noonan syndrome | Enrichment | MAP2K2 | 1.27 |
| 883 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.27 |
| 884 | Craniopharyngioma | Enrichment | BRAF | 1.27 |
| 885 | Newborn respiratory distress syndrome | Enrichment | BRAF | 1.27 |
| 886 | Intermediate nemaline myopathy | Enrichment | ACTA1 | 1.27 |
| 887 | Glioma | Enrichment | PTEN | 1.27 |
| 888 | Gingival fibromatosis | Enrichment | SOS1 | 1.27 |
| 889 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | SOS2 | 1.27 |
| 890 | Esophageal cancer | Enrichment | TGFBR2 | 1.26 |
| 891 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.26 |
| 892 | West syndrome | Enrichment | DNM1, GNAO1, PLCB1 | 1.23 |
| 893 | Van der woude syndrome 1 | Enrichment | CACNA1E | 1.23 |
| 894 | Gillespie syndrome | Enrichment | ITPR1 | 1.23 |
| 895 | Myopathy, centronuclear, x-linked | Enrichment | DNM2 | 1.23 |
| 896 | Developmental and epileptic encephalopathy 31b | Enrichment | DNM1 | 1.23 |
| 897 | Intraocular pressure quantitative trait locus | Enrichment | CREBBP | 1.23 |
| 898 | Melanoma of soft tissue | Enrichment | CREB1 | 1.23 |
| 899 | Thyrotoxic periodic paralysis | Enrichment | CACNA1S | 1.23 |
| 900 | Hypomyelination neuropathy-arthrogryposis syndrome | Enrichment | ADCY6 | 1.23 |
| 901 | Hereditary episodic ataxia | Enrichment | CACNA1A | 1.23 |
| 902 | Aortic aneurysm, familial thoracic 4 | Enrichment | MYH11 | 1.22 |
| 903 | Blepharocheilodontic syndrome 1 | Enrichment | CTNND1 | 1.22 |
| 904 | Arthrogryposis, distal, type 2a | Enrichment | MYH3 | 1.22 |
| 905 | Granulomatous disease, chronic, autosomal recessive, 1 | Enrichment | NCF1 | 1.22 |
| 906 | Ebstein anomaly | Enrichment | MYH7 | 1.22 |
| 907 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.22 |
| 908 | Cataract 35 | Enrichment | MYH9 | 1.22 |
| 909 | West nile virus | Enrichment | CCR5 | 1.22 |
| 910 | Isolated growth hormone deficiency, type iii, with agammaglobulinemia | Enrichment | BTK | 1.22 |
| 911 | Deafness, autosomal dominant 30 | Enrichment | MYO3A | 1.22 |
| 912 | Griscelli syndrome, type 3 | Enrichment | MYO5A | 1.22 |
| 913 | Arthrogryposis, distal, type 7 | Enrichment | MYH8 | 1.22 |
| 914 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 1.22 |
| 915 | Granulomatous disease, chronic, autosomal recessive, 3 | Enrichment | NCF4 | 1.22 |
| 916 | Long qt syndrome 14 | Enrichment | CALM1 | 1.22 |
| 917 | Arthrogryposis, distal, type 2b3 | Enrichment | MYH3 | 1.22 |
| 918 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 | Enrichment | MYH11 | 1.22 |
| 919 | Blepharocheilodontic syndrome 2 | Enrichment | CTNND1 | 1.22 |
| 920 | Agammaglobulinemia, x-linked | Enrichment | BTK | 1.22 |
| 921 | Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity | Enrichment | ESAM | 1.22 |
| 922 | Atrial septal defect 3 | Enrichment | MYH6 | 1.22 |
| 923 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.22 |
| 924 | Lymphoproliferative syndrome | Enrichment | ITK | 1.22 |
| 925 | Cardiomyopathy, familial hypertrophic, 10 | Enrichment | MYL2 | 1.22 |
| 926 | Deafness, autosomal recessive 29 | Enrichment | CLDN14 | 1.22 |
| 927 | Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome | Enrichment | MYH2 | 1.22 |
| 928 | Pseudosarcomatous fibromatosis | Enrichment | MYH9 | 1.22 |
| 929 | Visceral myopathy 2 | Enrichment | MYH11 | 1.22 |
| 930 | Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy | Enrichment | MYL2 | 1.22 |
| 931 | Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism | Enrichment | MYO18B | 1.22 |
| 932 | Arthrogryposis, distal, type 1c | Enrichment | MYL11 | 1.22 |
| 933 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 | Enrichment | MYL9 | 1.22 |
| 934 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.22 |
| 935 | Klippel-feil anomaly-myopathy-facial dysmorphism syndrome | Enrichment | MYO18B | 1.22 |
| 936 | Childhood-onset autosomal recessive myopathy with external ophthalmoplegia | Enrichment | MYH2 | 1.22 |
| 937 | Teratoma | Enrichment | CTNNB1 | 1.22 |
| 938 | Carney complex - trismus - pseudocamptodactyly syndrome | Enrichment | MYH8 | 1.22 |
| 939 | Gastroesophageal reflux | Enrichment | COL5A1 | 1.20 |
| 940 | Childhood-onset schizophrenia | Enrichment | FREM2 | 1.20 |
| 941 | Congenital nervous system abnormality | Enrichment | CACNA1A, CAMK2B, CREBBP, GNAO1, GNB5 | 1.20 |
| 942 | Nervous system disease | Enrichment | CACNA1A, CAMK2B, CREBBP, GNAO1, GNB5 | 1.20 |
| 943 | Alzheimer disease 2 | Enrichment | PLAU | 1.20 |
| 944 | Epidermolysis bullosa simplex 1c, localized | Enrichment | ITGB4 | 1.20 |
| 945 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative | Enrichment | JAK3 | 1.20 |
| 946 | Glanzmann thrombasthenia 2 | Enrichment | ITGB3 | 1.20 |
| 947 | Myeloproliferative neoplasm | Enrichment | JAK2 | 1.20 |
| 948 | Aplasia cutis congenita | Enrichment | ITGB4 | 1.20 |
| 949 | Spastic paraplegia 17, autosomal dominant | Enrichment | GNG3 | 1.19 |
| 950 | Pseudohypoparathyroidism, type ib | Enrichment | GNAS | 1.19 |
| 951 | Lipodystrophy, congenital generalized, type 2 | Enrichment | GNG3 | 1.19 |
| 952 | Arrhythmogenic right ventricular dysplasia, familial, 10 | Enrichment | PRKAR1A | 1.19 |
| 953 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | CDC42 | 1.19 |
| 954 | Centronuclear myopathy | Enrichment | CACNA1S, DNM2 | 1.18 |
| 955 | Body mass index quantitative trait locus 11 | Enrichment | ADCY3, GNAS, MYH9, SDC3 | 1.18 |
| 956 | Macrocephaly/autism syndrome | Enrichment | PTEN | 1.17 |
| 957 | Mosaic variegated aneuploidy syndrome 1 | Enrichment | PAK6 | 1.17 |
| 958 | Autosomal recessive limb-girdle muscular dystrophy type 2b | Enrichment | CAPN3 | 1.17 |
| 959 | Hemangioma | Enrichment | PTEN | 1.17 |
| 960 | Acute megakaryocytic leukemia | Enrichment | PTEN | 1.17 |
| 961 | Hemimegalencephaly | Enrichment | PTEN | 1.17 |
| 962 | Coloboma of choroid and retina | Enrichment | ACTG1 | 1.17 |
| 963 | Severe congenital nemaline myopathy | Enrichment | ACTA1 | 1.17 |
| 964 | Cornelia de lange syndrome 1 | Enrichment | SMC3 | 1.15 |
| 965 | Cornelia de lange syndrome | Enrichment | SMC3 | 1.15 |
| 966 | Chronic mucocutaneous candidiasis | Enrichment | STAT1 | 1.13 |
| 967 | Peters-plus syndrome | Enrichment | COL4A1 | 1.11 |
| 968 | Migraine, familial hemiplegic, 1 | Enrichment | CACNA1A | 1.11 |
| 969 | Chorea, benign hereditary | Enrichment | ADCY5 | 1.11 |
| 970 | Spinocerebellar ataxia 6 | Enrichment | CACNA1A | 1.11 |
| 971 | Aland island eye disease | Enrichment | CACNA1F | 1.11 |
| 972 | Developmental and epileptic encephalopathy 2 | Enrichment | CACNA1A | 1.11 |
| 973 | Ventricular fibrillation, paroxysmal familial, 1 | Enrichment | CACNA1C | 1.11 |
| 974 | Spinocerebellar ataxia 15 | Enrichment | ITPR1 | 1.11 |
| 975 | Developmental and epileptic encephalopathy 12 | Enrichment | PLCB1 | 1.11 |
| 976 | Developmental and epileptic encephalopathy 42 | Enrichment | CACNA1A | 1.11 |
| 977 | Cerebellar atrophy with seizures and variable developmental delay | Enrichment | CACNA2D2 | 1.11 |
| 978 | Developmental and epileptic encephalopathy 52 | Enrichment | CACNA1A | 1.11 |
| 979 | Hereditary ataxia | Enrichment | PRKCG | 1.11 |
| 980 | Malignant hyperthermia | Enrichment | CACNA1S | 1.11 |
| 981 | Episodic ataxia | Enrichment | CACNA1A | 1.11 |
| 982 | Familial or sporadic hemiplegic migraine | Enrichment | CACNA1A | 1.11 |
| 983 | Familial hypertrophic cardiomyopathy | Enrichment | MYH7, MYL2, MYL3 | 1.10 |
| 984 | Muscular dystrophy, limb-girdle, autosomal recessive 1 | Enrichment | CAPN3 | 1.10 |
| 985 | Wilms tumor 5 | Enrichment | BRAF | 1.10 |
| 986 | Capillary malformations, congenital | Enrichment | GNA11 | 1.09 |
| 987 | Diffuse cutaneous systemic sclerosis | Enrichment | CAV1 | 1.09 |
| 988 | Primary ovarian insufficiency | Enrichment | KDR, THBS1 | 1.09 |
| 989 | Cone dystrophy | Enrichment | CACNA2D4, GNAT2 | 1.08 |
| 990 | Ichthyosis | Enrichment | COL7A1 | 1.07 |
| 991 | Essential thrombocythemia | Enrichment | JAK2 | 1.06 |
| 992 | Epidermolysis bullosa simplex | Enrichment | ITGB4 | 1.06 |
| 993 | Amelogenesis imperfecta type 2 | Enrichment | MMP20 | 1.06 |
| 994 | Oligoarticular juvenile idiopathic arthritis | Enrichment | STAT4 | 1.06 |
| 995 | Overgrowth syndrome | Enrichment | PIK3R1 | 1.06 |
| 996 | Rheumatoid factor-negative juvenile idiopathic arthritis | Enrichment | STAT4 | 1.06 |
| 997 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.05 |
| 998 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | Enrichment | MYH9 | 1.05 |
| 999 | Klippel-feil syndrome 1, autosomal dominant | Enrichment | MYO18B | 1.05 |
| 1000 | Autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia | Enrichment | CYBA | 1.05 |
| 1001 | Deafness, autosomal recessive 3 | Enrichment | MYO15A | 1.05 |
| 1002 | Agammaglobulinemia 1, autosomal recessive | Enrichment | BTK | 1.05 |
| 1003 | Cardiomyopathy, dilated, 1c, with or without left ventricular noncompaction | Enrichment | MYH7B | 1.05 |
| 1004 | Spondylocarpotarsal synostosis syndrome | Enrichment | MYH3 | 1.05 |
| 1005 | Hepatitis c virus | Enrichment | CCR5 | 1.05 |
| 1006 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.05 |
| 1007 | Thrombocytopenia 5 | Enrichment | CLDN16 | 1.05 |
| 1008 | Anus, imperforate | Enrichment | CTNNB1 | 1.05 |
| 1009 | Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy | Enrichment | MYH15 | 1.05 |
| 1010 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.05 |
| 1011 | Agammaglobulinemia 1 | Enrichment | BTK | 1.05 |
| 1012 | Desmoid tumor | Enrichment | CTNNB1 | 1.05 |
| 1013 | Butterfly-shaped pigment dystrophy | Enrichment | CTNNA1 | 1.05 |
| 1014 | Qualitative or quantitative defects of beta-myosin heavy chain | Enrichment | MYH7 | 1.05 |
| 1015 | Idiopathic camptocormia | Enrichment | MYH7 | 1.05 |
| 1016 | Autoimmune polyendocrine syndrome type 1 | Enrichment | CYBA | 1.05 |
| 1017 | Congenital diarrhea | Enrichment | MYO1A | 1.05 |
| 1018 | Tricuspid valve insufficiency | Enrichment | MYH11 | 1.05 |
| 1019 | Cerebral sinovenous thrombosis | Enrichment | F2 | 1.05 |
| 1020 | Spastic ataxia | Enrichment | CACNA1G, CACNB4, ITPR1 | 1.04 |
| 1021 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3 | 1.03 |
| 1022 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3 | 1.03 |
| 1023 | Postsynaptic congenital myasthenic syndromes | Enrichment | COL13A1 | 1.03 |
| 1024 | Fetal akinesia deformation sequence 1 | Enrichment | ACTA1, FBN2 | 1.03 |
| 1025 | Childhood-onset nemaline myopathy | Enrichment | ACTA1 | 1.03 |
| 1026 | Cardiomyopathy, dilated, 1e | Enrichment | MYH7, MYL2 | 1.03 |
| 1027 | Hemihyperplasia, isolated | Enrichment | RHOA | 1.02 |
| 1028 | Limited scleroderma | Enrichment | CAV1 | 1.02 |
| 1029 | Episodic ataxia, type 2 | Enrichment | CACNA1A | 1.01 |
| 1030 | Night blindness, congenital stationary, type 1c | Enrichment | GNAT1 | 1.01 |
| 1031 | Developmental and epileptic encephalopathy 31a | Enrichment | DNM1 | 1.01 |
| 1032 | Heart conduction disease | Enrichment | CACNA1C | 1.01 |
| 1033 | Amblyopia | Enrichment | CACNA1F | 1.01 |
| 1034 | Cardiac arrest | Enrichment | CACNA2D1 | 1.01 |
| 1035 | Congenital short qt syndrome | Enrichment | CACNA2D1 | 1.01 |
| 1036 | Permanent neonatal diabetes mellitus | Enrichment | STAT3 | 1.01 |
| 1037 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | COL5A1 | 1.00 |
| 1038 | Clubfoot | Enrichment | COL5A1 | 1.00 |
| 1039 | Strabismus | Enrichment | CACNA1A, GNB1 | 0.99 |
| 1040 | Neuromuscular disease | Enrichment | ACTA1, MYH7 | 0.98 |
| 1041 | Lymphoma, non-hodgkin, familial | Enrichment | BRAF | 0.98 |
| 1042 | Mosaic variegated aneuploidy syndrome | Enrichment | PAK6 | 0.98 |
| 1043 | Walker-warburg syndrome | Enrichment | COL4A1 | 0.97 |
| 1044 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3 | 0.97 |
| 1045 | Leukemia, acute lymphoblastic 3 | Enrichment | JAK2 | 0.96 |
| 1046 | Renal agenesis, bilateral | Enrichment | ITGA8 | 0.96 |
| 1047 | Brachydactyly | Enrichment | GNAS | 0.95 |
| 1048 | Congenital myopathy | Enrichment | ACTA1, MYH7 | 0.95 |
| 1049 | Atypical hemolytic-uremic syndrome | Enrichment | COL4A5 | 0.94 |
| 1050 | Lynch syndrome | Enrichment | TGFBR2 | 0.94 |
| 1051 | Hypokalemic periodic paralysis, type 1 | Enrichment | CACNA1S | 0.94 |
| 1052 | Myopathy, centronuclear, 1 | Enrichment | DNM2 | 0.94 |
| 1053 | Rubinstein-taybi syndrome 1 | Enrichment | CREBBP | 0.94 |
| 1054 | Chromosome 16p13.3 deletion syndrome, proximal | Enrichment | CREBBP | 0.94 |
| 1055 | Spinocerebellar ataxia, autosomal recessive 16 | Enrichment | ITPR1 | 0.94 |
| 1056 | Hypertrichosis | Enrichment | CREBBP | 0.94 |
| 1057 | Childhood absence epilepsy | Enrichment | CACNA1H | 0.94 |
| 1058 | Infertility | Enrichment | GNRHR | 0.94 |
| 1059 | Myopathy, distal, 1 | Enrichment | MYH7 | 0.93 |
| 1060 | Klippel-feil syndrome 2, autosomal recessive | Enrichment | MYO18B | 0.93 |
| 1061 | Congenital myopathy 7b, myosin storage, autosomal recessive | Enrichment | MYH7 | 0.93 |
| 1062 | Polyposis syndrome, hereditary mixed, 1 | Enrichment | CTNNA1 | 0.93 |
| 1063 | Pilomatrixoma | Enrichment | CTNNB1 | 0.93 |
| 1064 | Congenital myopathy 7a, myosin storage, autosomal dominant | Enrichment | MYH7 | 0.93 |
| 1065 | Congenital myopathy 6 with ophthalmoplegia | Enrichment | MYH2 | 0.93 |
| 1066 | Alazami syndrome | Enrichment | CTNNB1 | 0.93 |
| 1067 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1b | Enrichment | MYH3 | 0.93 |
| 1068 | Hyaline body myopathy | Enrichment | MYH7 | 0.93 |
| 1069 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | MYH11 | 0.93 |
| 1070 | Adult hepatocellular carcinoma | Enrichment | EGF | 0.93 |
| 1071 | Ventricular septal defect | Enrichment | BRAF | 0.93 |
| 1072 | Limb-girdle muscular dystrophy | Enrichment | CAPN3 | 0.93 |
| 1073 | Gastric cancer | Enrichment | KRAS, PTEN | 0.92 |
| 1074 | Perrault syndrome 1 | Enrichment | FBN1 | 0.92 |
| 1075 | Autosomal non-syndromic agammaglobulinemia | Enrichment | PIK3R1 | 0.91 |
| 1076 | Williams-beuren syndrome | Enrichment | ELN, NCF1 | 0.91 |
| 1077 | Hypothyroidism | Enrichment | GNB1 | 0.90 |
| 1078 | Deafness, autosomal recessive | Enrichment | CLDN14, MYH9, MYO15A, MYO7A | 0.90 |
| 1079 | Cat eye syndrome | Enrichment | ACTG1 | 0.89 |
| 1080 | Autosomal recessive nonsyndromic deafness | Enrichment | CLDN14, MYH9, MYO15A, MYO7A | 0.88 |
| 1081 | Common variable immunodeficiency | Enrichment | NFKB1 | 0.88 |
| 1082 | Specific learning disability | Enrichment | MAPK1 | 0.88 |
| 1083 | Hepatoblastoma | Enrichment | COL7A1, CTNNB1 | 0.87 |
| 1084 | Polycystic kidney disease | Enrichment | COL4A4 | 0.87 |
| 1085 | Migraine with or without aura 1 | Enrichment | CAPN3 | 0.85 |
| 1086 | Meningioma, familial | Enrichment | PTEN | 0.85 |
| 1087 | Uterine corpus cancer | Enrichment | PTEN | 0.85 |
| 1088 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 0.84 |
| 1089 | Martsolf syndrome 1 | Enrichment | ARHGAP5 | 0.84 |
| 1090 | Arthrogryposis, distal, type 2b1 | Enrichment | MYH3 | 0.84 |
| 1091 | Deafness, autosomal recessive 9 | Enrichment | MYO15A | 0.84 |
| 1092 | Deafness, autosomal recessive 63 | Enrichment | MYH9 | 0.84 |
| 1093 | Otof-related hearing loss | Enrichment | MYO15A | 0.84 |
| 1094 | Alternating hemiplegia of childhood | Enrichment | CACNA1A | 0.82 |
| 1095 | Choreatic disease | Enrichment | GNAO1 | 0.82 |
| 1096 | Difference of sex development | Enrichment | CACNA1A | 0.82 |
| 1097 | Muscular dystrophy, limb-girdle, autosomal recessive 2 | Enrichment | CAPN3 | 0.81 |
| 1098 | Neural tube defects | Enrichment | ITGB1 | 0.81 |
| 1099 | Protein-deficiency anemia | Enrichment | NRAS | 0.81 |
| 1100 | Nk-cell enteropathy | Enrichment | JAK3 | 0.81 |
| 1101 | Visceral heterotaxy | Enrichment | LEFTY2 | 0.79 |
| 1102 | Aortic valve disease 1 | Enrichment | SOS1 | 0.78 |
| 1103 | Inflammatory bowel disease 1 | Enrichment | PRKCQ | 0.78 |
| 1104 | Developmental and epileptic encephalopathy 14 | Enrichment | PLCB1 | 0.78 |
| 1105 | Hypogonadotropic hypogonadism | Enrichment | GNRHR | 0.78 |
| 1106 | Leukemia, acute lymphoblastic | Enrichment | GNB1 | 0.77 |
| 1107 | Myelodysplastic syndrome | Enrichment | GNB1 | 0.77 |
| 1108 | Heritable pulmonary arterial hypertension | Enrichment | CAV1 | 0.77 |
| 1109 | Malaria | Enrichment | CD36 | 0.77 |
| 1110 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 0.77 |
| 1111 | Pendred syndrome | Enrichment | DIAPH1 | 0.77 |
| 1112 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1 | 0.77 |
| 1113 | Inherited arrhythmogenic cardiomyopathy | Enrichment | MYH7 | 0.77 |
| 1114 | Cleft lip with or without cleft palate | Enrichment | CTNND1 | 0.77 |
| 1115 | Autism | Enrichment | CAMK2G, COL11A1, CREBBP | 0.75 |
| 1116 | 46,xy partial gonadal dysgenesis | Enrichment | SOS1 | 0.75 |
| 1117 | Ciliary dyskinesia, primary, 3 | Enrichment | NFKB1 | 0.74 |
| 1118 | Achromatopsia | Enrichment | GNAT2 | 0.74 |
| 1119 | Auditory neuropathy | Enrichment | DIAPH1, MYO7A | 0.73 |
| 1120 | Wilms tumor 1 | Enrichment | BRAF | 0.72 |
| 1121 | Tetralogy of fallot | Enrichment | KDR | 0.72 |
| 1122 | Autism spectrum disorder | Enrichment | MAP2K1, PTEN, SMC3 | 0.72 |
| 1123 | Meniere disease | Enrichment | MYO7A | 0.71 |
| 1124 | Thrombophilia due to thrombin defect | Enrichment | F2 | 0.71 |
| 1125 | Familial isolated restrictive cardiomyopathy | Enrichment | MYL2 | 0.71 |
| 1126 | Alzheimer disease, familial, 1 | Enrichment | PLAU | 0.70 |
| 1127 | Charcot-marie-tooth disease | Enrichment | DNM2, LAMA2 | 0.70 |
| 1128 | Gliosarcoma | Enrichment | EGFR | 0.70 |
| 1129 | Epilepsy, myoclonic juvenile | Enrichment | CACNB4 | 0.70 |
| 1130 | Epilepsy, idiopathic generalized | Enrichment | CACNA1H | 0.70 |
| 1131 | Movement disease | Enrichment | GNAO1 | 0.70 |
| 1132 | Melanoma, cutaneous malignant 1 | Enrichment | BRAF | 0.68 |
| 1133 | Giant cell glioblastoma | Enrichment | EGFR | 0.68 |
| 1134 | Cardiac conduction defect | Enrichment | CACNA1C | 0.66 |
| 1135 | Congenital long qt syndrome | Enrichment | ITPR3 | 0.66 |
| 1136 | Behcet syndrome | Enrichment | STAT4 | 0.66 |
| 1137 | Arthrogryposis, distal, type 1a | Enrichment | MYH3 | 0.66 |
| 1138 | Basal ganglia calcification, idiopathic, 1 | Enrichment | JAM2 | 0.66 |
| 1139 | Perrault syndrome | Enrichment | CLDN14 | 0.66 |
| 1140 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 0.66 |
| 1141 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1 | 0.66 |
| 1142 | Myocarditis | Enrichment | MYH7 | 0.66 |
| 1143 | Hypoplastic left heart syndrome | Enrichment | MYH6 | 0.66 |
| 1144 | Cystic fibrosis | Enrichment | TGFB1 | 0.64 |
| 1145 | Stereotypic movement disorder | Enrichment | DNM1 | 0.63 |
| 1146 | Autosomal recessive limb-girdle muscular dystrophy | Enrichment | CAPN3 | 0.63 |
| 1147 | Complex neurodevelopmental disorder | Enrichment | CACNA1C, GNB2, PAK3, RAC3 | 0.62 |
| 1148 | Retinitis pigmentosa | Enrichment | COL18A1, IMPG1, IMPG2 | 0.61 |
| 1149 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | MYH7 | 0.61 |
| 1150 | Hypogonadotropic hypogonadism 7 with or without anosmia | Enrichment | GNRHR | 0.61 |
| 1151 | Heart disease | Enrichment | CREBBP | 0.61 |
| 1152 | Hypertension, essential | Enrichment | GNB3 | 0.60 |
| 1153 | Myocardial infarction | Enrichment | ITGB3 | 0.60 |
| 1154 | Endometrial cancer | Enrichment | PTEN | 0.59 |
| 1155 | Lissencephaly | Enrichment | ACTG1 | 0.59 |
| 1156 | Pancreatic cancer | Enrichment | KRAS | 0.56 |
| 1157 | Asthma | Enrichment | CCL11 | 0.54 |
| 1158 | Usher syndrome type 2 | Enrichment | MYO7A | 0.54 |
| 1159 | Left ventricular noncompaction | Enrichment | MYH7, MYH7B | 0.54 |
| 1160 | Early infantile developmental and epileptic encephalopathy | Enrichment | GNAO1 | 0.51 |
| 1161 | Attention deficit-hyperactivity disorder | Enrichment | GNB5 | 0.51 |
| 1162 | Restrictive cardiomyopathy | Enrichment | MYH7 | 0.51 |
| 1163 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | MYC | 0.49 |
| 1164 | Visceral heterotaxy 5 | Enrichment | MMP21 | 0.48 |
| 1165 | Microphthalmia/coloboma 12 | Enrichment | MYH10 | 0.48 |
| 1166 | Prostate cancer | Enrichment | PTEN | 0.48 |
| 1167 | Severe combined immunodeficiency | Enrichment | JAK3 | 0.46 |
| 1168 | Medulloblastoma | Enrichment | CTNNB1 | 0.45 |
| 1169 | Coloboma of macula | Enrichment | MYH10 | 0.43 |
| 1170 | Usher syndrome, type i | Enrichment | MYO7A | 0.43 |
| 1171 | Wolff-parkinson-white syndrome | Enrichment | MYH7 | 0.41 |
| 1172 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | CTNNA3 | 0.41 |
| 1173 | Isolated congenital microcephaly | Enrichment | OCLN | 0.41 |
| 1174 | Non-syndromic x-linked intellectual disability | Enrichment | ARHGEF6 | 0.40 |
| 1175 | Developmental and epileptic encephalopathy 1 | Enrichment | GNAO1 | 0.40 |
| 1176 | Sudden infant death syndrome | Enrichment | CALM2 | 0.39 |
| 1177 | Polycystic liver disease | Enrichment | CTNNB1 | 0.39 |
| 1178 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 0.39 |
| 1179 | Patent foramen ovale | Enrichment | MYH6 | 0.37 |
| 1180 | Craniosynostosis | Enrichment | CTNNA1 | 0.33 |
| 1181 | Hepatocellular carcinoma | Enrichment | CTNNB1 | 0.30 |
| 1182 | Familial atrial fibrillation | Enrichment | MYL4 | 0.28 |
| 1183 | Inherited cancer-predisposing syndrome | Enrichment | EGFR, PTEN | 0.26 |
| 1184 | Benign epilepsy with centrotemporal spikes | Enrichment | PLCB1 | 0.25 |
| 1185 | Centralopathic epilepsy | Enrichment | PLCB1 | 0.23 |
| 1186 | Optic atrophy plus syndrome | Enrichment | CACNA1F | 0.23 |
| 1187 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | PFN1 | 0.21 |
| 1188 | Usher syndrome | Enrichment | MYO7A | 0.19 |
| 1189 | Male infertility | Enrichment | CLDN2 | 0.19 |
| 1190 | Epilepsy | Enrichment | DIAPH1 | 0.15 |
| 1191 | Primary ciliary dyskinesia | Enrichment | PRKAR1B | 0.14 |
| 1192 | Autosomal recessive non-syndromic intellectual disability | Enrichment | EZR | 0.08 |